https://druglandscape.com/class/sglt2-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/vaccine2026-04-23weekly0.8 https://druglandscape.com/class/pd-1-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/corticosteroid2026-04-23weekly0.8 https://druglandscape.com/class/local-anesthetic2026-04-23weekly0.8 https://druglandscape.com/class/glp-1-receptor-agonist2026-04-23weekly0.8 https://druglandscape.com/class/live-attenuated-vaccine2026-04-23weekly0.8 https://druglandscape.com/class/calcineurin-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/opioid-analgesic2026-04-23weekly0.8 https://druglandscape.com/class/monoclonal-antibody2026-04-23weekly0.8 https://druglandscape.com/class/nonsteroidal-anti-inflammatory-drug-nsaid2026-04-23weekly0.8 https://druglandscape.com/class/atypical-antipsychotic2026-04-23weekly0.8 https://druglandscape.com/class/vaccine2026-04-23weekly0.8 https://druglandscape.com/class/pd-l1-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/inactivated-influenza-vaccine2026-04-23weekly0.8 https://druglandscape.com/class/conjugate-vaccine2026-04-23weekly0.8 https://druglandscape.com/class/inactivated-viral-vaccine2026-04-23weekly0.8 https://druglandscape.com/class/combination-vaccine2026-04-23weekly0.8 https://druglandscape.com/class/opioid-agonist2026-04-23weekly0.8 https://druglandscape.com/class/mrna-vaccine2026-04-23weekly0.8 https://druglandscape.com/class/inhaled-corticosteroid2026-04-23weekly0.8 https://druglandscape.com/class/topical-corticosteroid2026-04-23weekly0.8 https://druglandscape.com/class/local-anesthetic-amide2026-04-23weekly0.8 https://druglandscape.com/class/kinase-inhibitor-epc2026-04-23weekly0.8 https://druglandscape.com/class/proton-pump-inhibitor-ppi2026-04-23weekly0.8 https://druglandscape.com/class/benzodiazepine2026-04-23weekly0.8 https://druglandscape.com/class/corticosteroid-glucocorticoid2026-04-23weekly0.8 https://druglandscape.com/class/combination-chemotherapy-regimen2026-04-23weekly0.8 https://druglandscape.com/class/hmg-coa-reductase-inhibitor-statin2026-04-23weekly0.8 https://druglandscape.com/class/pi3k-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/anticoagulant2026-04-23weekly0.8 https://druglandscape.com/class/nmda-receptor-antagonist2026-04-23weekly0.8 https://druglandscape.com/class/gnrh-agonist2026-04-23weekly0.8 https://druglandscape.com/class/unknown2026-04-23weekly0.8 https://druglandscape.com/class/dpp-4-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/alkylating-agent2026-04-23weekly0.8 https://druglandscape.com/class/inhaled-corticosteroid-long-acting-beta-2-agonist-combination2026-04-23weekly0.8 https://druglandscape.com/class/probiotic2026-04-23weekly0.8 https://druglandscape.com/class/osmotic-laxative2026-04-23weekly0.8 https://druglandscape.com/class/small-molecule2026-04-23weekly0.8 https://druglandscape.com/class/ace-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/gonadotropin2026-04-23weekly0.8 https://druglandscape.com/class/platinum-based-chemotherapy2026-04-23weekly0.8 https://druglandscape.com/class/erythropoiesis-stimulating-agent-esa2026-04-23weekly0.8 https://druglandscape.com/class/low-molecular-weight-heparin-lmwh2026-04-23weekly0.8 https://druglandscape.com/class/tnf-alpha-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/macrolide-antibiotic2026-04-23weekly0.8 https://druglandscape.com/class/opioid-analgesic-combination2026-04-23weekly0.8 https://druglandscape.com/class/rapid-acting-insulin-analog2026-04-23weekly0.8 https://druglandscape.com/class/selective-serotonin-reuptake-inhibitor-ssri2026-04-23weekly0.8 https://druglandscape.com/class/vitamin-c-epc2026-04-20weekly0.8 https://druglandscape.com/class/jak-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/hiv-protease-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/nsaid2026-04-23weekly0.8 https://druglandscape.com/class/cell-therapy2026-04-23weekly0.8 https://druglandscape.com/class/long-acting-beta-2-agonist-laba2026-04-23weekly0.8 https://druglandscape.com/class/botulinum-toxin2026-04-23weekly0.8 https://druglandscape.com/class/fluoroquinolone-antibiotic2026-04-23weekly0.8 https://druglandscape.com/class/platinum-based-chemotherapy-agent2026-04-23weekly0.8 https://druglandscape.com/class/tyrosine-kinase-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/retinoid2026-04-23weekly0.8 https://druglandscape.com/class/antimalarial-combination2026-04-22weekly0.8 https://druglandscape.com/class/biguanide2026-04-23weekly0.8 https://druglandscape.com/class/direct-acting-antiviral-daa-combination2026-04-23weekly0.8 https://druglandscape.com/class/integrase-strand-transfer-inhibitor-insti2026-04-23weekly0.8 https://druglandscape.com/class/antimalarial2026-04-23weekly0.8 https://druglandscape.com/class/angiotensin-ii-receptor-blocker-arb2026-04-23weekly0.8 https://druglandscape.com/class/bisphosphonate2026-04-23weekly0.8 https://druglandscape.com/class/glucocorticoid2026-04-23weekly0.8 https://druglandscape.com/class/artificial-tear-ocular-lubricant2026-04-23weekly0.8 https://druglandscape.com/class/recombinant-protein-vaccine2026-04-23weekly0.8 https://druglandscape.com/class/car-t-cell-therapy2026-04-23weekly0.8 https://druglandscape.com/class/progestin2026-04-23weekly0.8 https://druglandscape.com/class/fgfr-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/nonsteroidal-anti-inflammatory-drug-epc2026-04-20weekly0.8 https://druglandscape.com/class/gene-therapy2026-04-23weekly0.8 https://druglandscape.com/class/interferon2026-04-23weekly0.8 https://druglandscape.com/class/glucocorticoid-corticosteroid2026-04-23weekly0.8 https://druglandscape.com/class/pi3k-delta-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/therapeutic-vaccine2026-04-23weekly0.8 https://druglandscape.com/class/antifibrinolytic-agent2026-04-23weekly0.8 https://druglandscape.com/class/tnf-inhibitor-monoclonal-antibody2026-04-23weekly0.8 https://druglandscape.com/class/bispecific-antibody2026-04-23weekly0.8 https://druglandscape.com/class/alpha-2-adrenergic-agonist2026-04-23weekly0.8 https://druglandscape.com/class/local-anesthetic-amide-class2026-04-23weekly0.8 https://druglandscape.com/class/antiviral-combination-therapy2026-04-23weekly0.8 https://druglandscape.com/class/beta-lactam-antibiotic-with-beta-lactamase-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/radioactive-diagnostic-agent-epc2026-04-20weekly0.8 https://druglandscape.com/class/alpha-2-adrenergic-receptor-agonist2026-04-23weekly0.8 https://druglandscape.com/class/immunomodulator2026-04-23weekly0.8 https://druglandscape.com/class/nucleoside-reverse-transcriptase-inhibitor-nrti2026-04-23weekly0.8 https://druglandscape.com/class/pd-1-pd-l1-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/prostaglandin-f-analog2026-04-23weekly0.8 https://druglandscape.com/class/partial-mu-opioid-receptor-agonist2026-04-23weekly0.8 https://druglandscape.com/class/viral-vector-vaccine2026-04-23weekly0.8 https://druglandscape.com/class/pneumococcal-conjugate-vaccine2026-04-23weekly0.8 https://druglandscape.com/class/loop-diuretic2026-04-23weekly0.8 https://druglandscape.com/class/insulin2026-04-23weekly0.8 https://druglandscape.com/class/nucleoside-analog-antiviral2026-04-23weekly0.8 https://druglandscape.com/class/anticholinergic2026-04-23weekly0.8 https://druglandscape.com/class/protease-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/tetracycline-antibiotic2026-04-23weekly0.8 https://druglandscape.com/class/taxane2026-04-23weekly0.8 https://druglandscape.com/class/phosphodiesterase-4-pde4-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/iron-supplement2026-04-23weekly0.8 https://druglandscape.com/class/inhaled-corticosteroid-long-acting-beta-2-agonist-combination-ics-laba2026-04-23weekly0.8 https://druglandscape.com/class/analgesic-and-antipyretic2026-04-23weekly0.8 https://druglandscape.com/class/aromatase-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/long-acting-basal-insulin2026-04-23weekly0.8 https://druglandscape.com/class/antimetabolite2026-04-23weekly0.8 https://druglandscape.com/class/pde4-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/non-nucleoside-reverse-transcriptase-inhibitor-nnrti2026-04-23weekly0.8 https://druglandscape.com/class/immune-checkpoint-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/calcium-channel-blocker2026-04-23weekly0.8 https://druglandscape.com/class/allergen-immunotherapy2026-04-23weekly0.8 https://druglandscape.com/class/not-specified2026-04-20weekly0.8 https://druglandscape.com/class/immunosuppressive-combination-therapy2026-04-23weekly0.8 https://druglandscape.com/class/combined-oral-contraceptive2026-04-23weekly0.8 https://druglandscape.com/class/mtor-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/antibody-drug-conjugate-adc2026-04-23weekly0.8 https://druglandscape.com/class/selective-cox-2-inhibitor-coxib2026-04-23weekly0.8 https://druglandscape.com/class/intravenous-immunoglobulin-ivig2026-04-23weekly0.8 https://druglandscape.com/class/serotonin-norepinephrine-reuptake-inhibitor-snri2026-04-23weekly0.8 https://druglandscape.com/class/btk-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/live-attenuated-viral-vaccine2026-04-23weekly0.8 https://druglandscape.com/class/dopamine-agonist2026-04-23weekly0.8 https://druglandscape.com/class/5-ht3-receptor-antagonist2026-04-23weekly0.8 https://druglandscape.com/class/egfr-tyrosine-kinase-inhibitor2026-04-23weekly0.8 https://druglandscape.com/class/nk1-receptor-antagonist2026-04-23weekly0.8 https://druglandscape.com/class/chemotherapy-combination-regimen2026-04-23weekly0.8 https://druglandscape.com/class/s1p-receptor-modulator2026-04-23weekly0.8 https://druglandscape.com/class/standardized-chemical-allergen-epc2026-04-21weekly0.8 https://druglandscape.com/class/imidazole-antifungal2026-04-23weekly0.8 https://druglandscape.com/class/influenza-vaccine2026-04-23weekly0.7 https://druglandscape.com/class/kinase-inhibitor2026-04-20weekly0.7 https://druglandscape.com/class/central-nervous-system-stimulant2026-04-23weekly0.7 https://druglandscape.com/class/vitamin-d-analog2026-04-23weekly0.7 https://druglandscape.com/class/parp-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/inactivated-influenza-vaccine2026-04-23weekly0.7 https://druglandscape.com/class/nicotinic-acetylcholine-receptor-agonist2026-04-23weekly0.7 https://druglandscape.com/class/enzyme-replacement-therapy2026-04-23weekly0.7 https://druglandscape.com/class/rifamycin-antibiotic2026-04-23weekly0.7 https://druglandscape.com/class/chemotherapy2026-04-23weekly0.7 https://druglandscape.com/class/vegf-inhibitor-monoclonal-antibody2026-04-23weekly0.7 https://druglandscape.com/class/non-standardized-plant-allergenic-extract-epc2026-04-20weekly0.7 https://druglandscape.com/class/androgen-replacement-therapy2026-04-23weekly0.7 https://druglandscape.com/class/iron-replacement-agent2026-04-23weekly0.7 https://druglandscape.com/class/meningococcal-conjugate-vaccine2026-04-23weekly0.7 https://druglandscape.com/class/nonsteroidal-anti-inflammatory-drug-nsaid-antiplatelet-agent2026-04-23weekly0.7 https://druglandscape.com/class/sulfonylurea2026-04-23weekly0.7 https://druglandscape.com/class/carbonic-anhydrase-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/monoclonal-antibody2026-04-23weekly0.7 https://druglandscape.com/class/botulinum-toxin-type-a2026-04-23weekly0.7 https://druglandscape.com/class/taxane-microtubule-stabilizer2026-04-23weekly0.7 https://druglandscape.com/class/corticosteroid2026-04-23weekly0.7 https://druglandscape.com/class/recombinant-vaccine2026-04-23weekly0.7 https://druglandscape.com/class/pcsk9-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/cholinesterase-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/aminoglycoside-antibiotic2026-04-23weekly0.7 https://druglandscape.com/class/long-acting-muscarinic-antagonist-lama2026-04-23weekly0.7 https://druglandscape.com/class/antibiotic2026-04-23weekly0.7 https://druglandscape.com/class/factor-xa-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/neuraminidase-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/therapeutic-cancer-vaccine2026-04-23weekly0.7 https://druglandscape.com/class/triazole-antifungal2026-04-23weekly0.7 https://druglandscape.com/class/sympathomimetic-amine-cns-stimulant2026-04-23weekly0.7 https://druglandscape.com/class/inactivated-viral-vaccine2026-04-23weekly0.7 https://druglandscape.com/class/monoclonal-antibody-anti-cd202026-04-23weekly0.7 https://druglandscape.com/class/intranasal-corticosteroid2026-04-23weekly0.7 https://druglandscape.com/class/artemisinin-based-combination-therapy-act2026-04-23weekly0.7 https://druglandscape.com/class/topical-antibiotic-combination2026-04-23weekly0.7 https://druglandscape.com/class/cephalosporin-antibacterial2026-04-20weekly0.7 https://druglandscape.com/class/immunosuppressant2026-04-23weekly0.7 https://druglandscape.com/class/beta-lactam-antibiotic2026-04-23weekly0.7 https://druglandscape.com/class/selective-estrogen-receptor-modulator-serm2026-04-23weekly0.7 https://druglandscape.com/class/anticholinergic-agent2026-04-23weekly0.7 https://druglandscape.com/class/cdk4-6-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/melatonin-receptor-agonist2026-04-23weekly0.7 https://druglandscape.com/class/thrombopoietin-receptor-agonist2026-04-23weekly0.7 https://druglandscape.com/class/antibiotic-combination2026-04-23weekly0.7 https://druglandscape.com/class/nucleoside-analog2026-04-23weekly0.7 https://druglandscape.com/class/antimalarial-combination-therapy2026-04-23weekly0.7 https://druglandscape.com/class/rankl-inhibitor-monoclonal-antibody2026-04-23weekly0.7 https://druglandscape.com/class/gnrh-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/nitroimidazole-antibiotic2026-04-23weekly0.7 https://druglandscape.com/class/fluoropyrimidine-antimetabolite2026-04-23weekly0.7 https://druglandscape.com/class/monoclonal-antibody-chemotherapy-combination2026-04-23weekly0.7 https://druglandscape.com/class/gadolinium-based-contrast-agent2026-04-23weekly0.7 https://druglandscape.com/class/thyroid-hormone-replacement2026-04-23weekly0.7 https://druglandscape.com/class/somatostatin-analog2026-04-23weekly0.7 https://druglandscape.com/class/selective-estrogen-receptor-degrader-serd2026-04-23weekly0.7 https://druglandscape.com/class/ssri2026-04-23weekly0.7 https://druglandscape.com/class/sars-cov-2-main-protease-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/crystalloid-fluid-electrolyte-replacement-solution2026-04-23weekly0.7 https://druglandscape.com/class/corticosteroid-epc2026-04-27weekly0.7 https://druglandscape.com/class/programmed-death-receptor-1-blocking-antibody-epc2026-04-20weekly0.7 https://druglandscape.com/class/h1-receptor-antagonist-second-generation-antihistamine2026-04-23weekly0.7 https://druglandscape.com/class/alkylating-drug-epc2026-04-20weekly0.7 https://druglandscape.com/class/tyrosine-kinase-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/beta-2-adrenergic-agonist-short-acting2026-04-23weekly0.7 https://druglandscape.com/class/prostaglandin-analog2026-04-23weekly0.7 https://druglandscape.com/class/glycopeptide-antibiotic2026-04-23weekly0.7 https://druglandscape.com/class/non-standardized-food-allergenic-extract-epc2026-04-20weekly0.7 https://druglandscape.com/class/azole-antifungal2026-04-23weekly0.7 https://druglandscape.com/class/platinum-based-alkylating-agent2026-04-23weekly0.7 https://druglandscape.com/class/non-depolarizing-neuromuscular-blocking-agent2026-04-23weekly0.7 https://druglandscape.com/class/anticonvulsant-mood-stabilizer2026-04-23weekly0.7 https://druglandscape.com/class/dual-antiplatelet-agent2026-04-23weekly0.7 https://druglandscape.com/class/estrogen2026-04-20weekly0.7 https://druglandscape.com/class/cd20-targeting-monoclonal-antibody2026-04-23weekly0.7 https://druglandscape.com/class/s1p1-receptor-modulator2026-04-23weekly0.7 https://druglandscape.com/class/calcium-channel-blocker-dihydropyridine2026-04-23weekly0.7 https://druglandscape.com/class/leukocyte-growth-factor-epc2026-04-20weekly0.7 https://druglandscape.com/class/androgen-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/opioid-agonist2026-04-20weekly0.7 https://druglandscape.com/class/antimicrobial-agent-antiseptic2026-04-22weekly0.7 https://druglandscape.com/class/chemotherapy-regimen2026-04-23weekly0.7 https://druglandscape.com/class/pet-imaging-agent2026-04-23weekly0.7 https://druglandscape.com/class/photodynamic-therapy-agent2026-04-23weekly0.7 https://druglandscape.com/class/monoclonal-antibody-drug-conjugate2026-04-23weekly0.7 https://druglandscape.com/class/small-molecule2026-04-23weekly0.7 https://druglandscape.com/class/multi-targeted-tyrosine-kinase-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/local-anesthetic-liposomal-formulation2026-04-22weekly0.7 https://druglandscape.com/class/antiarrhythmic2026-04-23weekly0.7 https://druglandscape.com/class/serotonin-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/opioid2026-04-23weekly0.7 https://druglandscape.com/class/nucleoside-metabolic-inhibitor-epc2026-04-20weekly0.7 https://druglandscape.com/class/anticonvulsant-antiepileptic-agent2026-04-23weekly0.7 https://druglandscape.com/class/toxoid-vaccine2026-04-23weekly0.7 https://druglandscape.com/class/radiopharmaceutical2026-04-23weekly0.7 https://druglandscape.com/class/traditional-chinese-medicine-herbal-formulation2026-04-22weekly0.7 https://druglandscape.com/class/nitrate-vasodilator2026-04-23weekly0.7 https://druglandscape.com/class/nucleoside-analog-antimetabolite2026-04-23weekly0.7 https://druglandscape.com/class/topical-antiseptic2026-04-23weekly0.7 https://druglandscape.com/class/alpha-1-adrenergic-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/proton-pump-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/opioid-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/oxytocin-receptor-agonist2026-04-23weekly0.7 https://druglandscape.com/class/tnf-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/chemotherapy2026-04-23weekly0.7 https://druglandscape.com/class/small-molecule-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/ultrasound-contrast-agent2026-04-23weekly0.7 https://druglandscape.com/class/growth-factor2026-04-23weekly0.7 https://druglandscape.com/class/vitamin-d-supplement2026-04-23weekly0.7 https://druglandscape.com/class/angiotensin-ii-receptor-blocker-calcium-channel-blocker-combination2026-04-23weekly0.7 https://druglandscape.com/class/angiogenesis-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/il-6-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/chemotherapy-regimen2026-04-23weekly0.7 https://druglandscape.com/class/nicotine-replacement-therapy-nrt2026-04-22weekly0.7 https://druglandscape.com/class/electrolyte-replacement-solution2026-04-23weekly0.7 https://druglandscape.com/class/cgrp-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/azole-antifungal-epc2026-04-20weekly0.7 https://druglandscape.com/class/antiviral2026-04-23weekly0.7 https://druglandscape.com/class/oxazolidinone-antibiotic2026-04-23weekly0.7 https://druglandscape.com/class/direct-factor-xa-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/nucleoside-reverse-transcriptase-inhibitor-nrti-combination2026-04-23weekly0.7 https://druglandscape.com/class/third-generation-cephalosporin2026-04-23weekly0.7 https://druglandscape.com/class/estrogen-epc2026-04-20weekly0.7 https://druglandscape.com/class/mek-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/glucagon-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/opioid-agonist-antagonist-combination2026-04-23weekly0.7 https://druglandscape.com/class/topoisomerase-i-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/fibrinolytic-agent-thrombolytic2026-04-23weekly0.7 https://druglandscape.com/class/lincosamide-antibiotic2026-04-23weekly0.7 https://druglandscape.com/class/osmotic-diuretic2026-04-23weekly0.7 https://druglandscape.com/class/retinoid-peroxide-combination2026-04-23weekly0.7 https://druglandscape.com/class/angiotensin-ii-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/thiazide-diuretic-epc2026-04-20weekly0.7 https://druglandscape.com/class/local-anesthetic-combination2026-04-23weekly0.7 https://druglandscape.com/class/beta-lactam-antibiotic-aminopenicillin2026-04-22weekly0.7 https://druglandscape.com/class/long-acting-basal-insulin-analog2026-04-23weekly0.7 https://druglandscape.com/class/crystalloid-fluid-electrolyte-replacement2026-04-23weekly0.7 https://druglandscape.com/class/central-nervous-system-stimulant-epc2026-04-20weekly0.7 https://druglandscape.com/class/unknown2026-04-23weekly0.7 https://druglandscape.com/class/antisense-oligonucleotide2026-04-23weekly0.7 https://druglandscape.com/class/cannabinoid2026-04-23weekly0.7 https://druglandscape.com/class/antiretroviral-combination-therapy-protease-inhibitor-nucleoside-reverse-transcriptase-inhibitors2026-04-23weekly0.7 https://druglandscape.com/class/high-risk-qt-prolonging-agents2026-04-20weekly0.7 https://druglandscape.com/class/acetylcholine-release-inhibitor-epc2026-04-20weekly0.7 https://druglandscape.com/class/polysaccharide-vaccine2026-04-23weekly0.7 https://druglandscape.com/class/atypical-antipsychotic-epc2026-04-20weekly0.7 https://druglandscape.com/class/artificial-tear-ocular-lubricant2026-04-22weekly0.7 https://druglandscape.com/class/inhaled-corticosteroid-long-acting-beta-2-agonist-ics-laba-combination2026-04-23weekly0.7 https://druglandscape.com/class/hormone-replacement-therapy-hrt2026-04-23weekly0.7 https://druglandscape.com/class/prophylactic-vaccine2026-04-23weekly0.7 https://druglandscape.com/class/dopamine-precursor-with-peripheral-decarboxylase-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/adrenocorticotropic-hormone-epc2026-04-20weekly0.7 https://druglandscape.com/class/topical-fluoride-agent2026-04-23weekly0.7 https://druglandscape.com/class/amino-acid-supplement2026-04-23weekly0.7 https://druglandscape.com/class/oral-contraceptive-combined-estrogen-progestin2026-04-23weekly0.7 https://druglandscape.com/class/potassium-channel-blocker2026-04-23weekly0.7 https://druglandscape.com/class/cancer-vaccine2026-04-23weekly0.7 https://druglandscape.com/class/il-23-inhibitor-monoclonal-antibody2026-04-23weekly0.7 https://druglandscape.com/class/antimicrobial2026-04-23weekly0.7 https://druglandscape.com/class/allylamine-antifungal2026-04-23weekly0.7 https://druglandscape.com/class/selective-serotonin-reuptake-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/cd38-targeting-monoclonal-antibody2026-04-23weekly0.7 https://druglandscape.com/class/intermediate-acting-insulin2026-04-23weekly0.7 https://druglandscape.com/class/interferon-alpha2026-04-23weekly0.7 https://druglandscape.com/class/alpha-glucosidase-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/polyene-antifungal2026-04-23weekly0.7 https://druglandscape.com/class/antiplatelet-agent2026-04-23weekly0.7 https://druglandscape.com/class/nonsteroidal-anti-inflammatory-drug2026-04-20weekly0.7 https://druglandscape.com/class/retinoid-epc2026-04-20weekly0.7 https://druglandscape.com/class/traditional-chinese-medicine2026-04-23weekly0.7 https://druglandscape.com/class/photosensitizing-agent2026-04-23weekly0.7 https://druglandscape.com/class/glucagon-receptor-agonist2026-04-23weekly0.7 https://druglandscape.com/class/norepinephrine-dopamine-reuptake-inhibitor-ndri2026-04-22weekly0.7 https://druglandscape.com/class/antiretroviral-combination-therapy-nrti-nnrti2026-04-22weekly0.7 https://druglandscape.com/class/nucleoside-nucleotide-reverse-transcriptase-inhibitor-combination2026-04-23weekly0.7 https://druglandscape.com/class/iron-replacement-therapy2026-04-23weekly0.7 https://druglandscape.com/class/proteasome-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/inactivated-vaccine2026-04-23weekly0.7 https://druglandscape.com/class/sympathomimetic-amine-central-nervous-system-stimulant2026-04-23weekly0.7 https://druglandscape.com/class/nicotine-replacement-therapy2026-04-23weekly0.7 https://druglandscape.com/class/her2-targeted-monoclonal-antibody2026-04-23weekly0.7 https://druglandscape.com/class/histone-deacetylase-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/androgen2026-04-23weekly0.7 https://druglandscape.com/class/multi-agent-chemotherapy-regimen2026-04-23weekly0.7 https://druglandscape.com/class/local-anesthetic-ester2026-04-22weekly0.7 https://druglandscape.com/class/volatile-anesthetic2026-04-23weekly0.7 https://druglandscape.com/class/nsaid-nonsteroidal-anti-inflammatory-drug2026-04-23weekly0.7 https://druglandscape.com/class/beta-lactam-beta-lactamase-inhibitor-combination2026-04-23weekly0.7 https://druglandscape.com/class/penicillin-class-antibacterial2026-04-20weekly0.7 https://druglandscape.com/class/chemotherapy-combination-taxane-platinum-agent2026-04-23weekly0.7 https://druglandscape.com/class/atypical-antipsychotic2026-04-23weekly0.7 https://druglandscape.com/class/tricyclic-antidepressant2026-04-20weekly0.7 https://druglandscape.com/class/antiretroviral-combination-insti-nrti2026-04-23weekly0.7 https://druglandscape.com/class/pi3k-delta-and-pi3k-gamma-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/topical-antiseptic-disinfectant2026-04-23weekly0.7 https://druglandscape.com/class/iron-chelator2026-04-23weekly0.7 https://druglandscape.com/class/alpha-1-adrenergic-agonist2026-04-23weekly0.7 https://druglandscape.com/class/bispecific-t-cell-engager-bite2026-04-23weekly0.7 https://druglandscape.com/class/dihydropyridine-calcium-channel-blocker2026-04-23weekly0.7 https://druglandscape.com/class/inhaled-corticosteroid-ics2026-04-23weekly0.7 https://druglandscape.com/class/potassium-channel-opener2026-04-23weekly0.7 https://druglandscape.com/class/vegf-a-inhibitor-monoclonal-antibody-fragment2026-04-23weekly0.7 https://druglandscape.com/class/ctla-4-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/second-generation-cephalosporin2026-04-23weekly0.7 https://druglandscape.com/class/tumor-necrosis-factor-blocker-epc2026-04-20weekly0.7 https://druglandscape.com/class/retinoid2026-04-23weekly0.7 https://druglandscape.com/class/leukotriene-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/glycoprotein-iib-iiia-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/benzodiazepine-epc2026-04-20weekly0.7 https://druglandscape.com/class/bcl-2-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/hormonal-contraceptive2026-04-23weekly0.7 https://druglandscape.com/class/autologous-cell-therapy2026-04-23weekly0.7 https://druglandscape.com/class/first-generation-cephalosporin2026-04-22weekly0.7 https://druglandscape.com/class/androgen-receptor-degrader-sard2026-04-23weekly0.7 https://druglandscape.com/class/bispecific-checkpoint-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/vegf-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/endothelin-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/long-acting-muscarinic-antagonist-long-acting-beta-2-agonist-combination-lama-laba2026-04-23weekly0.7 https://druglandscape.com/class/p2y12-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/complement-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/bruton-s-tyrosine-kinase-btk-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/immunoglobulin-replacement-therapy2026-04-23weekly0.7 https://druglandscape.com/class/immunosuppressant2026-04-23weekly0.7 https://druglandscape.com/class/insulin-analog-epc2026-04-20weekly0.7 https://druglandscape.com/class/ophthalmic-lubricant2026-04-23weekly0.7 https://druglandscape.com/class/local-anesthetic-with-vasoconstrictor2026-04-22weekly0.7 https://druglandscape.com/class/purine-analog-antimetabolite2026-04-23weekly0.7 https://druglandscape.com/class/antiretroviral-combination-therapy2026-04-23weekly0.7 https://druglandscape.com/class/non-steroidal-anti-inflammatory-drug-nsaid2026-04-23weekly0.7 https://druglandscape.com/class/recombinant-enzyme2026-04-23weekly0.7 https://druglandscape.com/class/anticonvulsant-antiepileptic-drug2026-04-23weekly0.7 https://druglandscape.com/class/general-anesthetic2026-04-23weekly0.7 https://druglandscape.com/class/class-iii-antiarrhythmic-agent2026-04-23weekly0.7 https://druglandscape.com/class/dipeptidyl-peptidase-4-inhibitor-epc2026-04-20weekly0.7 https://druglandscape.com/class/thiazide-diuretic2026-04-23weekly0.7 https://druglandscape.com/class/synthetic-opioid-agonist2026-04-23weekly0.7 https://druglandscape.com/class/8-aminoquinoline-antimalarial2026-04-23weekly0.7 https://druglandscape.com/class/anticholinergic-agent-muscarinic-antagonist2026-04-22weekly0.7 https://druglandscape.com/class/antihistamine2026-04-23weekly0.7 https://druglandscape.com/class/histone-deacetylase-hdac-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/standardized-chemical-allergen2026-04-20weekly0.7 https://druglandscape.com/class/cyp17-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/sodium-activated-potassium-channel-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/topical-analgesic2026-04-23weekly0.7 https://druglandscape.com/class/insulin-combination-therapy2026-04-23weekly0.7 https://druglandscape.com/class/short-acting-beta-2-agonist-saba2026-04-23weekly0.7 https://druglandscape.com/class/topical-corticosteroid-class-i-super-potent2026-04-23weekly0.7 https://druglandscape.com/class/estrogen-receptor-agonist2026-04-23weekly0.7 https://druglandscape.com/class/cytokine2026-04-23weekly0.7 https://druglandscape.com/class/antineoplastic-agent2026-04-23weekly0.7 https://druglandscape.com/class/antineoplastic-agents2026-04-23weekly0.7 https://druglandscape.com/class/alk-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/antiparasitic-agent2026-04-23weekly0.7 https://druglandscape.com/class/nucleotide-reverse-transcriptase-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/hemostatic-agent2026-04-23weekly0.7 https://druglandscape.com/class/crystalloid-intravenous-fluid2026-04-23weekly0.7 https://druglandscape.com/class/lipid-emulsion-for-parenteral-nutrition2026-04-23weekly0.7 https://druglandscape.com/class/recombinant-protein-subunit-vaccine2026-04-23weekly0.7 https://druglandscape.com/class/echinocandin-antifungal2026-04-23weekly0.7 https://druglandscape.com/class/rapid-acting-insulin2026-04-23weekly0.7 https://druglandscape.com/class/radiographic-contrast-agent-epc2026-04-20weekly0.7 https://druglandscape.com/class/live-attenuated-influenza-vaccine-laiv2026-04-23weekly0.7 https://druglandscape.com/class/prostaglandin-analogue2026-04-23weekly0.7 https://druglandscape.com/class/prostaglandin-f-receptor-agonist2026-04-23weekly0.7 https://druglandscape.com/class/live-attenuated-vaccine-immunotherapy2026-04-22weekly0.7 https://druglandscape.com/class/hypomethylating-agent2026-04-23weekly0.7 https://druglandscape.com/class/androgen-receptor-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/polymyxin-antibiotic2026-04-23weekly0.7 https://druglandscape.com/class/acetylcholinesterase-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/il-17a-inhibitor-monoclonal-antibody2026-04-23weekly0.7 https://druglandscape.com/class/erythropoiesis-stimulating-agent2026-04-23weekly0.7 https://druglandscape.com/class/beta-2-adrenergic-receptor-agonist2026-04-23weekly0.7 https://druglandscape.com/class/allogeneic-mesenchymal-stem-cell-therapy2026-04-23weekly0.7 https://druglandscape.com/class/mood-stabilizer2026-04-23weekly0.7 https://druglandscape.com/class/neuromuscular-blocking-agent2026-04-23weekly0.7 https://druglandscape.com/class/bispecific-antibody-pd-1-tgf-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/bispecific-monoclonal-antibody2026-04-23weekly0.7 https://druglandscape.com/class/beta2-adrenergic-agonist2026-04-20weekly0.7 https://druglandscape.com/class/p2y12-receptor-antagonist-thienopyridine-antiplatelet-agent2026-04-22weekly0.7 https://druglandscape.com/class/beta-adrenergic-blocker2026-04-20weekly0.7 https://druglandscape.com/class/carbapenem-antibiotic2026-04-23weekly0.7 https://druglandscape.com/class/cd20-directed-cytolytic-antibody-epc2026-04-20weekly0.7 https://druglandscape.com/class/monoamine-oxidase-inhibitors2026-04-20weekly0.7 https://druglandscape.com/class/opioid-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/antiplatelet2026-04-23weekly0.7 https://druglandscape.com/class/cftr-modulator2026-04-23weekly0.7 https://druglandscape.com/class/gonadotropin-recombinant-fsh2026-04-23weekly0.7 https://druglandscape.com/class/tyk2-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/tnf-inhibitor-monoclonal-antibody-biosimilar2026-04-23weekly0.7 https://druglandscape.com/class/pde5-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/vitamin-d-epc2026-04-20weekly0.7 https://druglandscape.com/class/histamine-1-receptor-antagonist2026-04-20weekly0.7 https://druglandscape.com/class/polyclonal-antithymocyte-globulin-atg2026-04-23weekly0.7 https://druglandscape.com/class/potassium-competitive-acid-blocker-p-cab2026-04-23weekly0.7 https://druglandscape.com/class/prostacyclin-analog2026-04-23weekly0.7 https://druglandscape.com/class/nucleoside-analog-antimetabolite2026-04-23weekly0.7 https://druglandscape.com/class/triptan-5-ht1b-1d-receptor-agonist2026-04-23weekly0.7 https://druglandscape.com/class/nicotinic-receptor-partial-agonist2026-04-23weekly0.7 https://druglandscape.com/class/inosine-monophosphate-dehydrogenase-impdh-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/blood-product-plasma-derivative2026-04-23weekly0.7 https://druglandscape.com/class/antitubercular2026-04-23weekly0.7 https://druglandscape.com/class/nitroimidazole-antimicrobial2026-04-23weekly0.7 https://druglandscape.com/class/non-standardized-chemical-allergen-epc2026-04-20weekly0.7 https://druglandscape.com/class/protein-kinase-c-pkc-activator2026-04-23weekly0.7 https://druglandscape.com/class/inactivated-vaccine2026-04-23weekly0.7 https://druglandscape.com/class/cholinergic-muscarinic-antagonist2026-04-20weekly0.7 https://druglandscape.com/class/il-5-receptor-antagonist-monoclonal-antibody2026-04-23weekly0.7 https://druglandscape.com/class/gonadotropin-releasing-hormone-receptor-agonist2026-04-20weekly0.7 https://druglandscape.com/class/direct-oral-anticoagulant-doac2026-04-23weekly0.7 https://druglandscape.com/class/antacid2026-04-23weekly0.7 https://druglandscape.com/class/radiographic-contrast-agent2026-04-20weekly0.7 https://druglandscape.com/class/her2-neu-receptor-antagonist-epc2026-04-20weekly0.7 https://druglandscape.com/class/local-anesthetic-with-vasopressor2026-04-22weekly0.7 https://druglandscape.com/class/egfr-tyrosine-kinase-inhibitor-third-generation2026-04-23weekly0.7 https://druglandscape.com/class/intravenous-sedative-hypnotic2026-04-23weekly0.7 https://druglandscape.com/class/expectorant2026-04-23weekly0.7 https://druglandscape.com/class/recombinant-coagulation-factor-viii2026-04-22weekly0.7 https://druglandscape.com/class/recombinant-human-growth-hormone2026-04-23weekly0.7 https://druglandscape.com/class/amino-acid-epc2026-04-20weekly0.7 https://druglandscape.com/class/recombinant-subunit-vaccine2026-04-23weekly0.7 https://druglandscape.com/class/anthracycline-topoisomerase-ii-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/crystalloid-fluid-electrolyte-solution2026-04-23weekly0.7 https://druglandscape.com/class/viscosupplement2026-04-23weekly0.7 https://druglandscape.com/class/antiplatelet-agent-combination2026-04-23weekly0.7 https://druglandscape.com/class/intravenous-iron-replacement-agent2026-04-23weekly0.7 https://druglandscape.com/class/topical-wound-healing-agent2026-04-23weekly0.7 https://druglandscape.com/class/tlr7-agonist2026-04-23weekly0.7 https://druglandscape.com/class/orexin-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/dihydropyridine-calcium-channel-blocker-epc2026-04-20weekly0.7 https://druglandscape.com/class/sclerosing-agent2026-04-23weekly0.7 https://druglandscape.com/class/selective-androgen-receptor-modulator-sarm2026-04-23weekly0.7 https://druglandscape.com/class/antisense-oligonucleotide2026-04-23weekly0.7 https://druglandscape.com/class/cytochrome-p450-3a-inhibitor-epc2026-04-20weekly0.7 https://druglandscape.com/class/anti-epileptic-agent2026-04-20weekly0.7 https://druglandscape.com/class/thiazide-like-diuretic2026-04-23weekly0.7 https://druglandscape.com/class/fibrinolytic-agent-tissue-plasminogen-activator-tpa2026-04-23weekly0.7 https://druglandscape.com/class/estrogen-replacement-therapy2026-04-22weekly0.7 https://druglandscape.com/class/granulocyte-colony-stimulating-factor-g-csf-analog2026-04-23weekly0.7 https://druglandscape.com/class/anti-epileptic-agent-epc2026-04-20weekly0.7 https://druglandscape.com/class/alkylating-drug2026-04-20weekly0.7 https://druglandscape.com/class/anti-inflammatory2026-04-23weekly0.7 https://druglandscape.com/class/anticonvulsant2026-04-23weekly0.7 https://druglandscape.com/class/cdk9-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/topical-corticosteroid-class-iii-iv-potency2026-04-22weekly0.7 https://druglandscape.com/class/norepinephrine-reuptake-inhibitor-nri2026-04-23weekly0.7 https://druglandscape.com/class/antiepileptic-agent2026-04-23weekly0.7 https://druglandscape.com/class/norepinephrine-dopamine-reuptake-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/protease-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/antimetabolite-chemotherapy-combination2026-04-23weekly0.7 https://druglandscape.com/class/dna-methyltransferase-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/standardized-insect-venom-allergenic-extract-epc2026-04-20weekly0.7 https://druglandscape.com/class/microtubule-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/stem-cell-therapy2026-04-23weekly0.7 https://druglandscape.com/class/peritoneal-dialysis-solution2026-04-23weekly0.7 https://druglandscape.com/class/phosphate-binder2026-04-23weekly0.7 https://druglandscape.com/class/muscarinic-m3-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/egfr-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/pancreatic-enzyme-replacement-therapy2026-04-23weekly0.7 https://druglandscape.com/class/neurokinin-1-nk1-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/antifolate-antimetabolite2026-04-23weekly0.7 https://druglandscape.com/class/beta-2-adrenergic-agonist-short-acting-bronchodilator2026-04-23weekly0.7 https://druglandscape.com/class/bile-acid-sequestrant2026-04-23weekly0.7 https://druglandscape.com/class/beta-1-selective-adrenergic-antagonist-beta-blocker2026-04-23weekly0.7 https://druglandscape.com/class/local-anesthetic-opioid-combination2026-04-23weekly0.7 https://druglandscape.com/class/immunotherapy2026-04-23weekly0.7 https://druglandscape.com/class/basal-insulin-analog2026-04-23weekly0.7 https://druglandscape.com/class/neurotoxin-acetylcholine-release-inhibitor2026-04-22weekly0.7 https://druglandscape.com/class/general-anesthetic-combination2026-04-23weekly0.7 https://druglandscape.com/class/cd47-sirp-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/il-4-receptor-antagonist-monoclonal-antibody2026-04-23weekly0.7 https://druglandscape.com/class/human-immunodeficiency-virus-1-non-nucleoside-analog-reverse-transcriptase-inhibitor-epc2026-04-20weekly0.7 https://druglandscape.com/class/histamine-h3-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/erythropoiesis-stimulating-agent2026-04-23weekly0.7 https://druglandscape.com/class/hemostatic-agent-fibrin-sealant2026-04-23weekly0.7 https://druglandscape.com/class/her2-inhibitor-monoclonal-antibody2026-04-23weekly0.7 https://druglandscape.com/class/growth-hormone-analog2026-04-23weekly0.7 https://druglandscape.com/class/granulocyte-colony-stimulating-factor-g-csf2026-04-23weekly0.7 https://druglandscape.com/class/glucokinase-activator2026-04-23weekly0.7 https://druglandscape.com/class/g-csf-agonist2026-04-23weekly0.7 https://druglandscape.com/class/general-anesthetic-epc2026-04-20weekly0.7 https://druglandscape.com/class/gaba-a-receptor-agonist2026-04-23weekly0.7 https://druglandscape.com/class/glp-1-gip-receptor-agonist2026-04-23weekly0.7 https://druglandscape.com/class/androgen-receptor-inhibitor-epc2026-04-20weekly0.7 https://druglandscape.com/class/angiotensin-converting-enzyme-inhibitor2026-04-20weekly0.7 https://druglandscape.com/class/anthelmintic2026-04-23weekly0.7 https://druglandscape.com/class/sodium-activated-potassium-channel-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/topoisomerase-ii-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/anti-coagulant2026-04-20weekly0.7 https://druglandscape.com/class/5-aminosalicylic-acid-5-asa-agent2026-04-22weekly0.7 https://druglandscape.com/class/topical-corticosteroid-class-i-super-potent2026-04-22weekly0.7 https://druglandscape.com/class/topical-analgesic-trpv1-agonist2026-04-23weekly0.7 https://druglandscape.com/class/antibiotic-combination-therapy2026-04-23weekly0.7 https://druglandscape.com/class/antibody-drug-conjugate2026-04-23weekly0.7 https://druglandscape.com/class/thiazolidinedione2026-04-23weekly0.7 https://druglandscape.com/class/tnf-inhibitor-tnf-receptor-fusion-protein2026-04-22weekly0.7 https://druglandscape.com/class/pyrimidine-analog2026-04-23weekly0.7 https://druglandscape.com/class/antifolate-antimalarial-combination2026-04-23weekly0.7 https://druglandscape.com/class/antifungal2026-04-23weekly0.7 https://druglandscape.com/class/sulfonamide-antibiotic-combination2026-04-22weekly0.7 https://druglandscape.com/class/sublingual-immunotherapy-slit2026-04-23weekly0.7 https://druglandscape.com/class/statin-hmg-coa-reductase-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/sodium-glucose-cotransporter-2-inhibitor-epc2026-04-20weekly0.7 https://druglandscape.com/class/serotonin-1b-and-serotonin-1d-receptor-agonist2026-04-20weekly0.7 https://druglandscape.com/class/antimetabolite-folate-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/selective-relaxant-binding-agent2026-04-23weekly0.7 https://druglandscape.com/class/selective-androgen-receptor-modulator-sarm2026-04-23weekly0.7 https://druglandscape.com/class/antiplatelet-agent-nsaid2026-04-23weekly0.7 https://druglandscape.com/class/ribonucleotide-reductase-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/recombinant-hepatitis-b-vaccine2026-04-23weekly0.7 https://druglandscape.com/class/recombinant-coagulation-factor2026-04-23weekly0.7 https://druglandscape.com/class/recombinant-clotting-factor2026-04-23weekly0.7 https://druglandscape.com/class/recombinant-hpv-vaccine2026-04-23weekly0.7 https://druglandscape.com/class/radiopharmaceutical-pet-imaging-agent2026-04-23weekly0.7 https://druglandscape.com/class/radioligand-therapy2026-04-23weekly0.7 https://druglandscape.com/class/radioactive-diagnostic-agent2026-04-20weekly0.7 https://druglandscape.com/class/purine-nucleoside-analog2026-04-22weekly0.7 https://druglandscape.com/class/prostaglandin-e1-analog2026-04-23weekly0.7 https://druglandscape.com/class/artemisinin-derivative2026-04-22weekly0.7 https://druglandscape.com/class/prostaglandin-analog-epc2026-04-20weekly0.7 https://druglandscape.com/class/programmed-death-ligand-1-blocker-epc2026-04-20weekly0.7 https://druglandscape.com/class/glycopeptide-antibiotic2026-04-23weekly0.7 https://druglandscape.com/class/polychemotherapy-regimen2026-04-23weekly0.7 https://druglandscape.com/class/photosensitizer2026-04-23weekly0.7 https://druglandscape.com/class/phosphodiesterase-4-pde-4-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/phenothiazine2026-04-20weekly0.7 https://druglandscape.com/class/paramagnetic-contrast-agent2026-04-20weekly0.7 https://druglandscape.com/class/calcitonin-gene-related-peptide-receptor-antagonist2026-04-20weekly0.7 https://druglandscape.com/class/p2y12-receptor-antagonist-thienopyridine2026-04-22weekly0.7 https://druglandscape.com/class/alkalinizing-agent2026-04-23weekly0.7 https://druglandscape.com/class/osmotic-agent2026-04-23weekly0.7 https://druglandscape.com/class/cd47-antibody2026-04-23weekly0.7 https://druglandscape.com/class/cd47-sirp-axis-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/cftr-potentiator2026-04-23weekly0.7 https://druglandscape.com/class/opioid-antagonist2026-04-20weekly0.7 https://druglandscape.com/class/opioid2026-04-23weekly0.7 https://druglandscape.com/class/ox40-agonist-monoclonal-antibody2026-04-23weekly0.7 https://druglandscape.com/class/calcineurin-inhibitor-topical-immunosuppressant2026-04-22weekly0.7 https://druglandscape.com/class/non-benzodiazepine-hypnotic-z-drug2026-04-23weekly0.7 https://druglandscape.com/class/nitroimidazole-antimicrobial-epc2026-04-20weekly0.7 https://druglandscape.com/class/nitrate-vasodilator-epc2026-04-20weekly0.7 https://druglandscape.com/class/catecholamine-adrenergic-agonist2026-04-22weekly0.7 https://druglandscape.com/class/neurotoxin-acetylcholine-release-inhibitor2026-04-22weekly0.7 https://druglandscape.com/class/central-nervous-system-stimulant2026-04-23weekly0.7 https://druglandscape.com/class/allogeneic-cell-therapy2026-04-23weekly0.7 https://druglandscape.com/class/chemotherapy-combination-platinum-agent-taxane2026-04-23weekly0.7 https://druglandscape.com/class/multi-kinase-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/chemotherapy-regimen-combination2026-04-23weekly0.7 https://druglandscape.com/class/cholinesterase-inhibitor2026-04-20weekly0.7 https://druglandscape.com/class/coagulation-factor-replacement2026-04-23weekly0.7 https://druglandscape.com/class/collagenase-enzyme2026-04-22weekly0.7 https://druglandscape.com/class/colloid-volume-expander2026-04-23weekly0.7 https://druglandscape.com/class/alpha-1a-adrenergic-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/macrolide2026-04-20weekly0.7 https://druglandscape.com/class/lymphocyte-growth-factor-epc2026-04-20weekly0.7 https://druglandscape.com/class/loop-diuretic-epc2026-04-20weekly0.7 https://druglandscape.com/class/combination-lipid-lowering-agent-ezetimibe-statin2026-04-23weekly0.7 https://druglandscape.com/class/local-anesthetic-with-corticosteroid-adjuvant2026-04-23weekly0.7 https://druglandscape.com/class/complement-c3-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/complement-inhibitor-epc2026-04-20weekly0.7 https://druglandscape.com/class/live-biotherapeutic-product2026-04-23weekly0.7 https://druglandscape.com/class/live-attenuated-influenza-vaccine2026-04-23weekly0.7 https://druglandscape.com/class/lipoglycopeptide-antibiotic2026-04-23weekly0.7 https://druglandscape.com/class/vitamin-supplement2026-04-23weekly0.7 https://druglandscape.com/class/janus-kinase-inhibitor-epc2026-04-20weekly0.7 https://druglandscape.com/class/interleukin-6-receptor-antagonist-epc2026-04-20weekly0.7 https://druglandscape.com/class/interleukin-23-antagonist-epc2026-04-20weekly0.7 https://druglandscape.com/class/dermal-filler2026-04-22weekly0.7 https://druglandscape.com/class/direct-thrombin-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/vitamin-k-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/inactivated-combination-vaccine2026-04-23weekly0.7 https://druglandscape.com/class/immunosuppressant-impdh-inhibitor2026-04-22weekly0.7 https://druglandscape.com/class/vitamin-d3-analog2026-04-23weekly0.7 https://druglandscape.com/class/egfr-inhibitor-monoclonal-antibody2026-04-23weekly0.7 https://druglandscape.com/class/microtubule-inhibitor-anti-inflammatory-agent2026-04-22weekly0.7 https://druglandscape.com/class/alkylating-agent2026-04-23weekly0.7 https://druglandscape.com/class/gaba-receptor-agonist2026-04-23weekly0.7 https://druglandscape.com/class/coagulation-factor-replacement-therapy2026-04-23weekly0.7 https://druglandscape.com/class/nucleoside-metabolic-inhibitor2026-04-20weekly0.7 https://druglandscape.com/class/vascular-endothelial-growth-factor-inhibitor-epc2026-04-20weekly0.7 https://druglandscape.com/class/microtubule-inhibitor-epc2026-04-20weekly0.7 https://druglandscape.com/class/inactivated-quadrivalent-influenza-vaccine2026-04-23weekly0.7 https://druglandscape.com/class/microtubule-inhibitor2026-04-20weekly0.7 https://druglandscape.com/class/nutritional-supplement2026-04-23weekly0.7 https://druglandscape.com/class/cox-2-selective-inhibitor-coxib2026-04-23weekly0.7 https://druglandscape.com/class/combination-chemotherapy2026-04-23weekly0.7 https://druglandscape.com/class/fibrin-sealant2026-04-23weekly0.7 https://druglandscape.com/class/cgrp-monoclonal-antibody2026-04-23weekly0.7 https://druglandscape.com/class/cftr-corrector2026-04-23weekly0.7 https://druglandscape.com/class/dopamine-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/opioid-analgesic-with-abuse-deterrent-formulation2026-04-23weekly0.7 https://druglandscape.com/class/growth-hormone2026-04-23weekly0.7 https://druglandscape.com/class/cdk-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/il-6-receptor-antagonist-monoclonal-antibody2026-04-23weekly0.7 https://druglandscape.com/class/cd47-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/h1-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/opioid-partial-agonist2026-04-23weekly0.7 https://druglandscape.com/class/oral-contraceptive-combined-hormonal-contraceptive2026-04-23weekly0.7 https://druglandscape.com/class/long-acting-beta-2-agonist-long-acting-muscarinic-antagonist-laba-lama-combination2026-04-23weekly0.7 https://druglandscape.com/class/organ-preservation-solution2026-04-23weekly0.7 https://druglandscape.com/class/p2x3-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/p2x7-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/il-5-antagonist-monoclonal-antibody2026-04-23weekly0.7 https://druglandscape.com/class/car-t-cell-therapy2026-04-23weekly0.7 https://druglandscape.com/class/c5a-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/local-anesthetic-with-opioid-analgesic-combination2026-04-23weekly0.7 https://druglandscape.com/class/pcsk9-inhibitor-monoclonal-antibody2026-04-23weekly0.7 https://druglandscape.com/class/vasodilators-organic-nitrates2026-04-20weekly0.7 https://druglandscape.com/class/calcineurin-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/blood-product-cellular-therapy2026-04-23weekly0.7 https://druglandscape.com/class/pet-imaging-agent-radiopharmaceutical2026-04-23weekly0.7 https://druglandscape.com/class/vasopressor-agent2026-04-23weekly0.7 https://druglandscape.com/class/local-anesthetic-opioid-analgesic-combination2026-04-23weekly0.7 https://druglandscape.com/class/complement-c5-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/cannabinoid2026-04-23weekly0.7 https://druglandscape.com/class/human-immunodeficiency-virus-nucleoside-analog-reverse-transcriptase-inhibitor-epc2026-04-27weekly0.7 https://druglandscape.com/class/parathyroid-hormone-analog2026-04-23weekly0.7 https://druglandscape.com/class/beta-lactam-antibiotic-combination2026-04-22weekly0.7 https://druglandscape.com/class/personalized-neoantigen-vaccine2026-04-23weekly0.7 https://druglandscape.com/class/carbapenem-antibiotic2026-04-23weekly0.7 https://druglandscape.com/class/cell-therapy2026-04-23weekly0.7 https://druglandscape.com/class/beta-blocker2026-04-23weekly0.7 https://druglandscape.com/class/combination-vaccine2026-04-22weekly0.7 https://druglandscape.com/class/adenosine-a2a-receptor-agonist2026-04-23weekly0.7 https://druglandscape.com/class/potassium-binder2026-04-23weekly0.7 https://druglandscape.com/class/premixed-insulin2026-04-23weekly0.7 https://druglandscape.com/class/asparagine-specific-enzyme-epc2026-04-20weekly0.7 https://druglandscape.com/class/progestin-hormonal-contraceptive2026-04-22weekly0.7 https://druglandscape.com/class/immunosuppressant-combination2026-04-23weekly0.7 https://druglandscape.com/class/prostaglandin-e1-analogue2026-04-23weekly0.7 https://druglandscape.com/class/aromatic-amino-acid-epc2026-04-20weekly0.7 https://druglandscape.com/class/aromatase-inhibitor-epc2026-04-20weekly0.7 https://druglandscape.com/class/vitamin-steroid-hormone2026-04-23weekly0.7 https://druglandscape.com/class/antituberculous-agent2026-04-23weekly0.7 https://druglandscape.com/class/protein-subunit-vaccine2026-04-23weekly0.7 https://druglandscape.com/class/hdac-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/immunomodulatory-agent-imid2026-04-23weekly0.7 https://druglandscape.com/class/antiseptic-epc2026-04-20weekly0.7 https://druglandscape.com/class/antiretroviral-combination-therapy-integrase-inhibitor-nucleoside-reverse-transcriptase-inhibitors2026-04-23weekly0.7 https://druglandscape.com/class/antiretroviral2026-04-23weekly0.7 https://druglandscape.com/class/retinoid-third-generation2026-04-23weekly0.7 https://druglandscape.com/class/live-attenuated-vaccine2026-04-23weekly0.7 https://druglandscape.com/class/rho-kinase-rock-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/acth-analog2026-04-22weekly0.7 https://druglandscape.com/class/antimycobacterial-agent2026-04-23weekly0.7 https://druglandscape.com/class/cysteinyl-leukotriene-receptor-antagonist-ltra2026-04-22weekly0.7 https://druglandscape.com/class/viral-vector-vaccine2026-04-25weekly0.7 https://druglandscape.com/class/antimicrobial-antiseptic-agent2026-04-22weekly0.7 https://druglandscape.com/class/antimicrobial-peptide2026-04-23weekly0.7 https://druglandscape.com/class/antimicrobial-oral-rinse2026-04-22weekly0.7 https://druglandscape.com/class/her2-targeted-monoclonal-antibody-trastuzumab-biosimilar2026-04-23weekly0.7 https://druglandscape.com/class/janus-kinase-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/il-23-inhibitor-monoclonal-antibody2026-04-23weekly0.7 https://druglandscape.com/class/selective-estrogen-receptor-modulator2026-04-23weekly0.7 https://druglandscape.com/class/sigma-1-receptor-agonist2026-04-23weekly0.7 https://druglandscape.com/class/antimetabolite-folate-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/antimalarial-immunomodulator2026-04-23weekly0.7 https://druglandscape.com/class/antimalarial-epc2026-04-20weekly0.7 https://druglandscape.com/class/somatostatin-receptor-targeting-agent2026-04-23weekly0.7 https://druglandscape.com/class/sympathomimetic-amine-adrenergic-agonist2026-04-23weekly0.7 https://druglandscape.com/class/dpp-4-inhibitor-biguanide-combination2026-04-23weekly0.7 https://druglandscape.com/class/antifibrinolytic2026-04-23weekly0.7 https://druglandscape.com/class/antiepileptic-drug-aed2026-04-23weekly0.7 https://druglandscape.com/class/antidote2026-04-23weekly0.7 https://druglandscape.com/class/taxane-microtubule-stabilizer2026-04-23weekly0.7 https://druglandscape.com/class/thiazolidinedione-ppar-agonist2026-04-23weekly0.7 https://druglandscape.com/class/her2-targeted-monoclonal-antibody-combination2026-04-23weekly0.7 https://druglandscape.com/class/hif-1-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/interferon-beta2026-04-22weekly0.7 https://druglandscape.com/class/interferon-alpha-fusion-protein2026-04-23weekly0.7 https://druglandscape.com/class/herbal-immunomodulator2026-04-23weekly0.7 https://druglandscape.com/class/third-generation-egfr-tyrosine-kinase-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/topical-antimicrobial-and-anti-inflammatory-agent2026-04-23weekly0.7 https://druglandscape.com/class/topical-antimicrobial-and-keratolytic-agent2026-04-22weekly0.7 https://druglandscape.com/class/topical-combination-therapy-vitamin-d-analog-corticosteroid2026-04-23weekly0.7 https://druglandscape.com/class/topical-hemostatic-agent2026-04-22weekly0.7 https://druglandscape.com/class/topical-local-anesthetic2026-04-23weekly0.7 https://druglandscape.com/class/topoisomerase-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/sodium-channel-blocker2026-04-23weekly0.7 https://druglandscape.com/class/anthracycline-topoisomerase-inhibitor2026-04-20weekly0.7 https://druglandscape.com/class/5-ht7-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/insulin-combination-product2026-04-22weekly0.7 https://druglandscape.com/class/angiotensin-ii-receptor-blocker-thiazide-diuretic-combination2026-04-23weekly0.7 https://druglandscape.com/class/aminoglycoside-antibacterial2026-04-20weekly0.7 https://druglandscape.com/class/vitamin-k-antagonist-coumarin-anticoagulant2026-04-23weekly0.7 https://druglandscape.com/class/angiotensin-ii-receptor-blocker-thiazide-diuretic-combination2026-04-23weekly0.7 https://druglandscape.com/class/transthyretin-stabilizer2026-04-23weekly0.7 https://druglandscape.com/class/statin2026-04-23weekly0.7 https://druglandscape.com/class/tetracycline-antibiotic2026-04-23weekly0.7 https://druglandscape.com/class/amide-local-anesthetic2026-04-20weekly0.7 https://druglandscape.com/class/angiotensin-ii-receptor-antagonist-arb2026-04-22weekly0.7 https://druglandscape.com/class/anesthetic2026-04-23weekly0.7 https://druglandscape.com/class/vegf-inhibitor-antiangiogenic-agent2026-04-23weekly0.7 https://druglandscape.com/class/vegf-inhibitor-soluble-decoy-receptor2026-04-23weekly0.7 https://druglandscape.com/class/disease-modifying-antirheumatic-drug-dmard-combination2026-04-23weekly0.7 https://druglandscape.com/class/chemotherapy-combination-nucleoside-analog-taxane2026-04-23weekly0.7 https://druglandscape.com/class/muscarinic-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/chemotherapy-combination-nucleoside-analog-platinum-agent2026-04-23weekly0.7 https://druglandscape.com/class/amide-local-anesthetic-epc2026-04-20weekly0.7 https://druglandscape.com/class/ns5a-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/gabapentinoid-anticonvulsant-anxiolytic2026-04-23weekly0.7 https://druglandscape.com/class/nsaid-proton-pump-inhibitor-combination2026-04-23weekly0.7 https://druglandscape.com/class/natriuretic-peptide2026-04-23weekly0.7 https://druglandscape.com/class/mucolytic-agent2026-04-23weekly0.7 https://druglandscape.com/class/chelating-agent2026-04-23weekly0.7 https://druglandscape.com/class/cephalosporin-antibiotic2026-04-23weekly0.7 https://druglandscape.com/class/alpha-adrenergic-agonist-epc2026-04-20weekly0.7 https://druglandscape.com/class/neuroprotective-agent2026-04-23weekly0.7 https://druglandscape.com/class/alpha-adrenergic-blocker2026-04-20weekly0.7 https://druglandscape.com/class/neurotoxin-botulinum-toxin-type-a2026-04-22weekly0.7 https://druglandscape.com/class/glp-1-receptor-agonist-epc2026-05-12weekly0.7 https://druglandscape.com/class/catecholamine-sympathomimetic-amine2026-04-22weekly0.7 https://druglandscape.com/class/allergen-immunotherapy-sublingual-tablet2026-04-23weekly0.7 https://druglandscape.com/class/monoclonal-antibody2026-04-20weekly0.7 https://druglandscape.com/class/monoamine-oxidase-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/non-nucleoside-reverse-transcriptase-inhibitor2026-04-23weekly0.7 https://druglandscape.com/class/cholinergic-receptor-agonist2026-04-20weekly0.7 https://druglandscape.com/class/herbal-botanical-extract2026-04-22weekly0.7 https://druglandscape.com/class/non-opioid-analgesic2026-04-23weekly0.7 https://druglandscape.com/class/nondepolarizing-neuromuscular-blocker2026-04-20weekly0.7 https://druglandscape.com/class/anti-vegf-agent2026-04-23weekly0.7 https://druglandscape.com/class/monoamine-oxidase-inhibitor2026-04-20weekly0.7 https://druglandscape.com/class/calculi-dissolution-agent-epc2026-04-20weekly0.7 https://druglandscape.com/class/mineralocorticoid-receptor-antagonist2026-04-23weekly0.7 https://druglandscape.com/class/thyroid-hormone-replacement-therapy2026-04-23weekly0.6 https://druglandscape.com/class/ace2-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/allergen-immunotherapy-extract2026-04-23weekly0.6 https://druglandscape.com/class/alpha-2a-adrenergic-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/angiotensin-2-receptor-blocker2026-04-20weekly0.6 https://druglandscape.com/class/angiotensin-2-receptor-blocker-epc2026-04-20weekly0.6 https://druglandscape.com/class/angiotensin-ii-receptor-antagonist-thiazide-diuretic-combination2026-04-23weekly0.6 https://druglandscape.com/class/angiotensin-ii-receptor-blocker-calcium-channel-blocker-combination2026-04-23weekly0.6 https://druglandscape.com/class/angiotensin-receptor-blocker2026-04-23weekly0.6 https://druglandscape.com/class/anthelmintic-epc2026-04-20weekly0.6 https://druglandscape.com/class/anthracycline-chemotherapy-agent2026-04-23weekly0.6 https://druglandscape.com/class/anti-coagulant-epc2026-04-20weekly0.6 https://druglandscape.com/class/anti-tuberculosis-agent-fixed-dose-combination2026-04-23weekly0.6 https://druglandscape.com/class/antibiotic-corticosteroid-combination2026-04-23weekly0.6 https://druglandscape.com/class/anticholinergic-agent-muscarinic-receptor-antagonist2026-04-22weekly0.6 https://druglandscape.com/class/antidiabetic-combination-biguanide-thiazolidinedione2026-04-22weekly0.6 https://druglandscape.com/class/antifibrotic-agent2026-04-23weekly0.6 https://druglandscape.com/class/antimetabolite-folate-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/antimicrobial-agent2026-04-23weekly0.6 https://druglandscape.com/class/antimycobacterial2026-04-20weekly0.6 https://druglandscape.com/class/antineoplastic2026-04-23weekly0.6 https://druglandscape.com/class/antioxidant2026-04-23weekly0.6 https://druglandscape.com/class/antioxidant-mucolytic-agent2026-04-23weekly0.6 https://druglandscape.com/class/antiplatelet-combination-therapy2026-04-22weekly0.6 https://druglandscape.com/class/antiprotozoal2026-04-23weekly0.6 https://druglandscape.com/class/antipsychotic2026-04-22weekly0.6 https://druglandscape.com/class/antiretroviral-combination-therapy-nnrti-2-nrtis2026-04-23weekly0.6 https://druglandscape.com/class/antisense-oligonucleotide-epc2026-04-20weekly0.6 https://druglandscape.com/class/artificial-tear-lubricant2026-04-22weekly0.6 https://druglandscape.com/class/atypical-antipsychotic-combination2026-04-23weekly0.6 https://druglandscape.com/class/autologous-stem-cell-therapy2026-04-23weekly0.6 https://druglandscape.com/class/azole-antifungal2026-04-20weekly0.6 https://druglandscape.com/class/blys-inhibitor-monoclonal-antibody2026-04-22weekly0.6 https://druglandscape.com/class/bacterial-vaccine2026-04-23weekly0.6 https://druglandscape.com/class/barbiturate2026-04-23weekly0.6 https://druglandscape.com/class/benzimidazole-anthelmintic2026-04-23weekly0.6 https://druglandscape.com/class/beta-1-selective-adrenergic-receptor-antagonist-beta-blocker2026-04-22weekly0.6 https://druglandscape.com/class/beta-3-adrenergic-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/beta-adrenergic-antagonist2026-04-22weekly0.6 https://druglandscape.com/class/beta-blocker-with-alpha-1-antagonist-activity2026-04-22weekly0.6 https://druglandscape.com/class/beta-blocker-with-alpha-1-blocking-activity2026-04-23weekly0.6 https://druglandscape.com/class/bile-acid2026-04-23weekly0.6 https://druglandscape.com/class/bispecific-cd20-directed-cd3-t-cell-engager-epc2026-04-20weekly0.6 https://druglandscape.com/class/blood-product-hemostatic-agent2026-04-23weekly0.6 https://druglandscape.com/class/bone-graft-substitute2026-04-23weekly0.6 https://druglandscape.com/class/bowel-preparation-agent-laxative-combination2026-04-23weekly0.6 https://druglandscape.com/class/car-t-cell-therapy2026-04-23weekly0.6 https://druglandscape.com/class/ccr4-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/ccr5-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/cd33-directed-immunoconjugate-epc2026-04-20weekly0.6 https://druglandscape.com/class/cd73-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/cftr-modulator-combination-corrector-potentiator2026-04-23weekly0.6 https://druglandscape.com/class/calcitonin-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/calcium-channel-blocker-beta-blocker-combination2026-04-23weekly0.6 https://druglandscape.com/class/cannabinoid-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/carnitine-analog-epc2026-04-20weekly0.6 https://druglandscape.com/class/catecholamine2026-04-20weekly0.6 https://druglandscape.com/class/cell-therapy-regenerative-medicine2026-04-23weekly0.6 https://druglandscape.com/class/central-alpha-2-adrenergic-agonist2026-04-20weekly0.6 https://druglandscape.com/class/chemotherapeutic-agent2026-04-23weekly0.6 https://druglandscape.com/class/chemotherapy-pd-1-inhibitor-combination2026-04-23weekly0.6 https://druglandscape.com/class/chemotherapy-combination-platinum-agent-antimetabolite2026-04-23weekly0.6 https://druglandscape.com/class/chemotherapy-combination-with-anti-angiogenic-monoclonal-antibody2026-04-23weekly0.6 https://druglandscape.com/class/cholinesterase-inhibitor-with-anticholinergic-agent2026-04-23weekly0.6 https://druglandscape.com/class/coagulation-factor-concentrate2026-04-23weekly0.6 https://druglandscape.com/class/combination-bronchodilator-anticholinergic-beta-2-agonist2026-04-23weekly0.6 https://druglandscape.com/class/combination-chemotherapy-fluoropyrimidine-platinum-agent2026-04-23weekly0.6 https://druglandscape.com/class/complement-c5a-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/contrast-agent2026-04-23weekly0.6 https://druglandscape.com/class/corneal-cross-linking-agent2026-04-23weekly0.6 https://druglandscape.com/class/corticosteroid-topical-class-i-super-potent2026-04-22weekly0.6 https://druglandscape.com/class/corticosteroid-and-long-acting-beta2-adrenergic-receptor-agonist-combination2026-04-23weekly0.6 https://druglandscape.com/class/cytokine-hematopoietic-growth-factor2026-04-23weekly0.6 https://druglandscape.com/class/dietary-supplement-nutraceutical2026-04-22weekly0.6 https://druglandscape.com/class/direct-acting-antiviral2026-04-23weekly0.6 https://druglandscape.com/class/direct-acting-antiviral-combination-ns3-4a-protease-inhibitor-ns5a-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/dissociative-anesthetic2026-04-22weekly0.6 https://druglandscape.com/class/dopamine-d2-receptor-agonist2026-04-22weekly0.6 https://druglandscape.com/class/dopamine-d2-d3-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/dual-glp-1-gip-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/egfr-inhibitor-monoclonal-antibody2026-04-23weekly0.6 https://druglandscape.com/class/electrolyte-solution2026-04-23weekly0.6 https://druglandscape.com/class/electrolyte-supplement-anticonvulsant2026-04-23weekly0.6 https://druglandscape.com/class/endoglycosidase-epc2026-04-20weekly0.6 https://druglandscape.com/class/endothelin-receptor-antagonist-epc2026-04-20weekly0.6 https://druglandscape.com/class/enzyme2026-04-23weekly0.6 https://druglandscape.com/class/erythropoietin-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/estrogen-receptor-antagonist-epc2026-04-20weekly0.6 https://druglandscape.com/class/factor-viii-replacement-therapy2026-04-23weekly0.6 https://druglandscape.com/class/fatty-acid2026-04-23weekly0.6 https://druglandscape.com/class/fcrn-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/fibrinolytic-agent2026-04-23weekly0.6 https://druglandscape.com/class/fluoroquinolone2026-04-20weekly0.6 https://druglandscape.com/class/folate-antagonist-antimetabolite2026-04-23weekly0.6 https://druglandscape.com/class/gaba-a-receptor-positive-allosteric-modulator2026-04-22weekly0.6 https://druglandscape.com/class/gene-therapy-aav-vector2026-04-23weekly0.6 https://druglandscape.com/class/gonadotropin-releasing-hormone-receptor-antagonist2026-04-20weekly0.6 https://druglandscape.com/class/gonadotropin-epc2026-04-20weekly0.6 https://druglandscape.com/class/hif-prolyl-hydroxylase-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/hiv-protease-inhibitor-combination2026-04-23weekly0.6 https://druglandscape.com/class/hmg-coa-reductase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/hedgehog-pathway-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/heparin-antagonist-anticoagulant-reversal-agent2026-04-22weekly0.6 https://druglandscape.com/class/hepatitis-b-virus-nucleoside-analog-reverse-transcriptase-inhibitor-epc2026-04-24weekly0.6 https://druglandscape.com/class/hepatitis-c-virus-ns5a-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/herbal-extract-natural-product2026-04-22weekly0.6 https://druglandscape.com/class/histamine-2-receptor-antagonist-epc2026-04-20weekly0.6 https://druglandscape.com/class/histone-deacetylase-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/hydrolytic-lysosomal-glycosaminoglycan-specific-enzyme-epc2026-04-20weekly0.6 https://druglandscape.com/class/il-12-il-23-inhibitor-monoclonal-antibody2026-04-23weekly0.6 https://druglandscape.com/class/il-1-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/il-6-inhibitor-monoclonal-antibody2026-04-23weekly0.6 https://druglandscape.com/class/ige-monoclonal-antibody2026-04-23weekly0.6 https://druglandscape.com/class/immunoglobulin-replacement-therapy-immunomodulator2026-04-23weekly0.6 https://druglandscape.com/class/immunotoxin2026-04-23weekly0.6 https://druglandscape.com/class/inactivated-influenza-vaccine-quadrivalent2026-04-23weekly0.6 https://druglandscape.com/class/inhaled-vasodilator2026-04-23weekly0.6 https://druglandscape.com/class/insulin-analog2026-04-23weekly0.6 https://druglandscape.com/class/insulin-glp-1-receptor-agonist-combination2026-04-23weekly0.6 https://druglandscape.com/class/interleukin-12-antagonist-epc2026-04-20weekly0.6 https://druglandscape.com/class/iron-supplement-erythropoiesis-stimulating-agent-esa2026-04-23weekly0.6 https://druglandscape.com/class/jak1-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/kras-g12c-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/lipid-emulsion-epc2026-04-20weekly0.6 https://druglandscape.com/class/lipoglycopeptide-antibacterial2026-04-20weekly0.6 https://druglandscape.com/class/live-attenuated-combination-vaccine2026-04-23weekly0.6 https://druglandscape.com/class/live-biotherapeutic-product-probiotic2026-04-23weekly0.6 https://druglandscape.com/class/long-acting-beta-2-agonist-inhaled-corticosteroid-combination2026-04-23weekly0.6 https://druglandscape.com/class/low-molecular-weight-heparin2026-04-23weekly0.6 https://druglandscape.com/class/medical-gas2026-04-23weekly0.6 https://druglandscape.com/class/methylating-agent-epc2026-04-20weekly0.6 https://druglandscape.com/class/monoclonal-antibody-anti-tfpi2026-04-22weekly0.6 https://druglandscape.com/class/monoclonal-antibody-combination2026-04-23weekly0.6 https://druglandscape.com/class/morpholine-antifungal2026-04-22weekly0.6 https://druglandscape.com/class/muscarinic-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/muscle-relaxant-epc2026-04-20weekly0.6 https://druglandscape.com/class/nlrp3-inflammasome-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/nmda-receptor-antagonist-combination2026-04-23weekly0.6 https://druglandscape.com/class/nsaid-with-proton-pump-inhibitor-combination2026-04-22weekly0.6 https://druglandscape.com/class/neuromuscular-blocking-agent-non-depolarizing2026-04-23weekly0.6 https://druglandscape.com/class/neurotoxin2026-04-23weekly0.6 https://druglandscape.com/class/neurotoxin-neuromuscular-blocking-agent2026-04-22weekly0.6 https://druglandscape.com/class/non-ionic-iodinated-contrast-medium2026-04-22weekly0.6 https://druglandscape.com/class/non-ionic-iso-osmolar-contrast-medium2026-04-22weekly0.6 https://druglandscape.com/class/nonbenzodiazepine-hypnotic-z-drug2026-04-23weekly0.6 https://druglandscape.com/class/nucleoside-nucleotide-reverse-transcriptase-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/nucleoside-nucleotide-reverse-transcriptase-inhibitor-nrti-ntrti-combination2026-04-22weekly0.6 https://druglandscape.com/class/nucleotide-reverse-transcriptase-inhibitor-ntrti2026-04-23weekly0.6 https://druglandscape.com/class/nutritional-supplement-combination2026-04-23weekly0.6 https://druglandscape.com/class/omega-3-fatty-acid2026-04-23weekly0.6 https://druglandscape.com/class/opioid-analgesic-with-monoamine-reuptake-inhibition2026-04-23weekly0.6 https://druglandscape.com/class/p2y12-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/p2y12-platelet-receptor-antagonist2026-04-22weekly0.6 https://druglandscape.com/class/p2y12-receptor-antagonist-antiplatelet-agent2026-04-23weekly0.6 https://druglandscape.com/class/p2y12-receptor-antagonist-antiplatelet-agent2026-04-22weekly0.6 https://druglandscape.com/class/pd-1-inhibitor-chemotherapy-combination2026-04-23weekly0.6 https://druglandscape.com/class/pde10a-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/pi3k-mtor-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/parenteral-iron-replacement-epc2026-04-20weekly0.6 https://druglandscape.com/class/parenteral-nutrition-emulsion2026-04-22weekly0.6 https://druglandscape.com/class/pediculicide2026-04-22weekly0.6 https://druglandscape.com/class/pentavalent-inactivated-vaccine2026-04-23weekly0.6 https://druglandscape.com/class/peptide-hormone2026-04-23weekly0.6 https://druglandscape.com/class/phytotherapeutic2026-04-23weekly0.6 https://druglandscape.com/class/plasma-kallikrein-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/polyclonal-antithymocyte-antibody2026-04-22weekly0.6 https://druglandscape.com/class/positron-emission-tomography-pet-imaging-agent2026-04-22weekly0.6 https://druglandscape.com/class/progesterone-receptor-antagonist-prostaglandin-analog-combination2026-04-23weekly0.6 https://druglandscape.com/class/progestin-contraceptive2026-04-22weekly0.6 https://druglandscape.com/class/prostaglandin-e2-analog2026-04-23weekly0.6 https://druglandscape.com/class/protease-inhibitor2026-04-20weekly0.6 https://druglandscape.com/class/protease-inhibitor-combination2026-04-23weekly0.6 https://druglandscape.com/class/protein-kinase-c-activator2026-04-23weekly0.6 https://druglandscape.com/class/quinolone-antimicrobial2026-04-20weekly0.6 https://druglandscape.com/class/rankl-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/radiopharmaceutical-diagnostic-agent2026-04-23weekly0.6 https://druglandscape.com/class/reduced-folate-cofactor-chemotherapy-adjuvant2026-04-23weekly0.6 https://druglandscape.com/class/regenerative-medicine2026-04-23weekly0.6 https://druglandscape.com/class/retinoid-x-receptor-rxr-agonist2026-04-22weekly0.6 https://druglandscape.com/class/rho-kinase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/s1p1-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/sedative-hypnotic2026-04-23weekly0.6 https://druglandscape.com/class/selective-estrogen-receptor-modulator-serm2026-04-23weekly0.6 https://druglandscape.com/class/selective-serotonin-reuptake-inhibitor-ssri2026-04-20weekly0.6 https://druglandscape.com/class/serotonin-5-ht3-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/serotonin-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/short-acting-beta-2-adrenergic-agonist-saba2026-04-23weekly0.6 https://druglandscape.com/class/soluble-guanylate-cyclase-sgc-activator2026-04-23weekly0.6 https://druglandscape.com/class/soluble-guanylate-cyclase-stimulator2026-04-23weekly0.6 https://druglandscape.com/class/sulfone-antibiotic-with-anti-inflammatory-properties2026-04-23weekly0.6 https://druglandscape.com/class/synthetic-cannabinoid2026-04-23weekly0.6 https://druglandscape.com/class/synthetic-colloid-plasma-volume-expander2026-04-23weekly0.6 https://druglandscape.com/class/synthetic-colloid-plasma-volume-expander2026-04-22weekly0.6 https://druglandscape.com/class/t-cell-costimulation-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/tnf-receptor-antagonist2026-04-22weekly0.6 https://druglandscape.com/class/tnf-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/tnf-inhibitor-biosimilar2026-04-23weekly0.6 https://druglandscape.com/class/trpv1-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/thiazide-diuretic2026-04-20weekly0.6 https://druglandscape.com/class/thiazolidinedione-biguanide-combination2026-04-23weekly0.6 https://druglandscape.com/class/thyroid-hormone2026-04-23weekly0.6 https://druglandscape.com/class/topical-nsaid2026-04-23weekly0.6 https://druglandscape.com/class/topical-antiseptic-combination2026-04-23weekly0.6 https://druglandscape.com/class/topoisomerase-inhibitor2026-04-20weekly0.6 https://druglandscape.com/class/traditional-chinese-medicine-compound2026-04-23weekly0.6 https://druglandscape.com/class/triple-combination-inhaler-ics-lama-laba2026-04-23weekly0.6 https://druglandscape.com/class/vegf-inhibitor-monoclonal-antibody-fragment2026-04-23weekly0.6 https://druglandscape.com/class/vasopressin-analog2026-04-23weekly0.6 https://druglandscape.com/class/wound-healing-agent2026-04-23weekly0.6 https://druglandscape.com/class/beta-lactamase-inhibitor2026-04-20weekly0.6 https://druglandscape.com/class/botulinum-toxin-type-a-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/dopamine-agonist2026-04-23weekly0.6 https://druglandscape.com/class/fluoroquinolone-antibiotic2026-04-23weekly0.6 https://druglandscape.com/class/gonadotropin2026-04-23weekly0.6 https://druglandscape.com/class/insulin2026-04-23weekly0.6 https://druglandscape.com/class/norepinephrine-reuptake-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/nucleoside-analog2026-04-23weekly0.6 https://druglandscape.com/class/opioid-analgesic2026-04-23weekly0.6 https://druglandscape.com/class/opioid-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/orexin-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/topical-retinoid2026-04-23weekly0.6 https://druglandscape.com/class/vasodilator2026-04-23weekly0.6 https://druglandscape.com/class/bacterial-lysate-immunostimulant2026-04-22weekly0.6 https://druglandscape.com/class/bacterial-rna-polymerase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/monoclonal-antibody-anti-amyloid-beta2026-04-23weekly0.6 https://druglandscape.com/class/somatostatin-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/copper-containing-intrauterine-device-epc2026-04-20weekly0.6 https://druglandscape.com/class/convalescent-plasma2026-04-23weekly0.6 https://druglandscape.com/class/pleuromutilin-antibiotic2026-04-23weekly0.6 https://druglandscape.com/class/sphingosine-1-phosphate-receptor-modulator2026-04-23weekly0.6 https://druglandscape.com/class/calcium-channel-blocker-ace-inhibitor-combination2026-04-22weekly0.6 https://druglandscape.com/class/pneumococcal-polysaccharide-vaccine2026-04-22weekly0.6 https://druglandscape.com/class/antihypertensive-combination-arb-calcium-channel-blocker-thiazide-diuretic2026-04-22weekly0.6 https://druglandscape.com/class/poly-adp-ribose-polymerase-inhibitor2026-04-20weekly0.6 https://druglandscape.com/class/homeopathic-combination-remedy2026-04-23weekly0.6 https://druglandscape.com/class/calcium-channel-blocker-angiotensin-ii-receptor-blocker-combination2026-04-22weekly0.6 https://druglandscape.com/class/statin-proton-pump-inhibitor-combination2026-04-22weekly0.6 https://druglandscape.com/class/not-available2026-04-20weekly0.6 https://druglandscape.com/class/bcr-abl-tyrosine-kinase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/statins2026-04-23weekly0.6 https://druglandscape.com/class/antihistamine-decongestant-combination2026-04-22weekly0.6 https://druglandscape.com/class/dpp-4-inhibitor-and-biguanide2026-04-23weekly0.6 https://druglandscape.com/class/local-anesthetic-nsaid-combination2026-04-22weekly0.6 https://druglandscape.com/class/direct-acting-antiviral-daa-ns5a-inhibitor2026-04-19weekly0.6 https://druglandscape.com/class/calcium-channel-blocker-non-dihydropyridine2026-04-23weekly0.6 https://druglandscape.com/class/polysaccharide-conjugate-vaccine2026-04-23weekly0.6 https://druglandscape.com/class/stimulant-laxative2026-04-22weekly0.6 https://druglandscape.com/class/antifungal-antiparasitic-combination2026-04-23weekly0.6 https://druglandscape.com/class/inhaled-corticosteroid-long-acting-beta-2-agonist-long-acting-muscarinic-antagonist-ics-laba-lama2026-04-22weekly0.6 https://druglandscape.com/class/il-23-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/autologous-cell-therapy-regenerative-medicine-product2026-04-22weekly0.6 https://druglandscape.com/class/autologous-cell-therapy-regenerative-medicine2026-04-23weekly0.6 https://druglandscape.com/class/monoclonal-antibody-il-4-receptor-antagonist2026-04-22weekly0.6 https://druglandscape.com/class/mood-stabilizer-epc2026-04-20weekly0.6 https://druglandscape.com/class/antifungal-agent2026-04-23weekly0.6 https://druglandscape.com/class/sulfonamide-anticonvulsant2026-04-23weekly0.6 https://druglandscape.com/class/hypomethylating-agent-combined-with-chemotherapy-regimen2026-04-23weekly0.6 https://druglandscape.com/class/atypical-antipsychotic-anticonvulsant-mood-stabilizer-combination2026-04-23weekly0.6 https://druglandscape.com/class/electrolyte-solution-fluid-replacement2026-04-23weekly0.6 https://druglandscape.com/class/combined-hormonal-contraceptive2026-04-22weekly0.6 https://druglandscape.com/class/immunostimulant2026-04-23weekly0.6 https://druglandscape.com/class/antifolate-antimetabolite-platinum-based-chemotherapy-combination2026-04-23weekly0.6 https://druglandscape.com/class/sulfonylurea-biguanide-combination2026-04-23weekly0.6 https://druglandscape.com/class/sulfonylurea-epc2026-04-20weekly0.6 https://druglandscape.com/class/sunscreen2026-04-23weekly0.6 https://druglandscape.com/class/surfactant-epc2026-04-20weekly0.6 https://druglandscape.com/class/nucleoside-reverse-transcriptase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/histamine-1-receptor-antagonist-epc2026-04-20weekly0.6 https://druglandscape.com/class/sympathomimetic-amine2026-04-22weekly0.6 https://druglandscape.com/class/antifolate-antimalarial2026-04-22weekly0.6 https://druglandscape.com/class/sympathomimetic-amine-catecholamine2026-04-23weekly0.6 https://druglandscape.com/class/atypical-antipsychotic2026-04-20weekly0.6 https://druglandscape.com/class/antifoaming-agent2026-04-22weekly0.6 https://druglandscape.com/class/sympathomimetic-amine-adrenergic-agonist2026-04-22weekly0.6 https://druglandscape.com/class/insulin-human-recombinant2026-04-23weekly0.6 https://druglandscape.com/class/cytotoxic-chemotherapy2026-04-23weekly0.6 https://druglandscape.com/class/antifibrotic2026-04-23weekly0.6 https://druglandscape.com/class/progesterone-epc2026-04-20weekly0.6 https://druglandscape.com/class/progesterone-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/progesterone-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/multi-agent-chemotherapy-combination2026-04-23weekly0.6 https://druglandscape.com/class/adenosine-a1-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/calcineurin-inhibitor-immunosuppressant-epc2026-04-20weekly0.6 https://druglandscape.com/class/synthetic-opioid-analgesic2026-04-23weekly0.6 https://druglandscape.com/class/artificial-tear-lubricant2026-04-23weekly0.6 https://druglandscape.com/class/calcimimetic-agent2026-04-23weekly0.6 https://druglandscape.com/class/progestin-only-contraceptive2026-04-23weekly0.6 https://druglandscape.com/class/progestin-long-acting-reversible-contraceptive-larc2026-04-22weekly0.6 https://druglandscape.com/class/tgf-receptor-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/ics-laba-combination2026-04-23weekly0.6 https://druglandscape.com/class/combination-topical-agent-vitamin-d-analog-corticosteroid2026-04-22weekly0.6 https://druglandscape.com/class/tlr9-agonist2026-04-23weekly0.6 https://druglandscape.com/class/tnf-blocker2026-04-24weekly0.6 https://druglandscape.com/class/beta-adrenergic-blocker-epc2026-04-20weekly0.6 https://druglandscape.com/class/antiemetic2026-04-23weekly0.6 https://druglandscape.com/class/tnf-inhibitor-dmard-combination2026-04-22weekly0.6 https://druglandscape.com/class/nutritional-supplement-mineral-and-vitamin-combination2026-04-22weekly0.6 https://druglandscape.com/class/artificial-tear-lubricating-agent2026-04-22weekly0.6 https://druglandscape.com/class/estrogen-replacement-therapy2026-04-23weekly0.6 https://druglandscape.com/class/tnf-alpha-inhibitor-dmard-combination2026-04-23weekly0.6 https://druglandscape.com/class/prokinetic-agent2026-04-22weekly0.6 https://druglandscape.com/class/insulin-short-acting2026-04-22weekly0.6 https://druglandscape.com/class/chemotherapy-combination-platinum-agent-nucleoside-analog2026-04-22weekly0.6 https://druglandscape.com/class/prostacyclin-analogue2026-04-23weekly0.6 https://druglandscape.com/class/omega-3-fatty-acid-triglyceride-lowering-agent2026-04-23weekly0.6 https://druglandscape.com/class/antidiabetic-combination-therapy2026-04-23weekly0.6 https://druglandscape.com/class/omega-3-fatty-acid-supplement2026-04-22weekly0.6 https://druglandscape.com/class/antidiabetic-combination-biguanide-sulfonylurea2026-04-22weekly0.6 https://druglandscape.com/class/tau-aggregation-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/muscarinic-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/anticonvulsant-sodium-channel-blocker2026-04-22weekly0.6 https://druglandscape.com/class/adrenergic-receptor-agonist2026-04-20weekly0.6 https://druglandscape.com/class/taxane-and-platinum-based-chemotherapy2026-04-23weekly0.6 https://druglandscape.com/class/chemotherapy-combination-nucleoside-analog-platinum-alkylating-agent2026-04-23weekly0.6 https://druglandscape.com/class/insulin-sglt2-inhibitor-combination2026-04-22weekly0.6 https://druglandscape.com/class/taxane-microtubule-stabilizing-agent2026-04-23weekly0.6 https://druglandscape.com/class/aromatase-inhibitor-steroidal2026-04-23weekly0.6 https://druglandscape.com/class/antiviral-agent2026-04-22weekly0.6 https://druglandscape.com/class/prostaglandin-f2-analog2026-04-22weekly0.6 https://druglandscape.com/class/cxcr4-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/tetracycline-class-antibacterial-epc2026-04-20weekly0.6 https://druglandscape.com/class/thalidomide-analog-epc2026-04-20weekly0.6 https://druglandscape.com/class/prostaglandin-analog-beta-blocker-combination2026-04-22weekly0.6 https://druglandscape.com/class/anticoagulant-antiplatelet-agent-combination2026-04-22weekly0.6 https://druglandscape.com/class/human-immunoglobulin-g-epc2026-04-20weekly0.6 https://druglandscape.com/class/ctla-4-directed-blocking-antibody-epc2026-04-20weekly0.6 https://druglandscape.com/class/epidermal-growth-factor-receptor-antagonist-epc2026-04-20weekly0.6 https://druglandscape.com/class/thiazide-like-diuretic-epc2026-04-20weekly0.6 https://druglandscape.com/class/anticholinergic-antispasmodic2026-04-23weekly0.6 https://druglandscape.com/class/anticholinergic-epc2026-04-20weekly0.6 https://druglandscape.com/class/antituberculous-combination-therapy2026-04-22weekly0.6 https://druglandscape.com/class/8-aminoquinoline2026-04-23weekly0.6 https://druglandscape.com/class/csf1r-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/beta-blocker2026-04-23weekly0.6 https://druglandscape.com/class/immunosuppressive-combination-regimen2026-04-22weekly0.6 https://druglandscape.com/class/thrombolytic2026-04-23weekly0.6 https://druglandscape.com/class/thrombolytic-agent2026-04-23weekly0.6 https://druglandscape.com/class/tafamidis2026-04-20weekly0.6 https://druglandscape.com/class/electrolyte-replacement2026-04-23weekly0.6 https://druglandscape.com/class/thymic-stromal-lymphopoietin-blocker-epc2026-04-20weekly0.6 https://druglandscape.com/class/cytokine-interferon2026-04-23weekly0.6 https://druglandscape.com/class/long-acting-beta2-adrenergic-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/11-hsd1-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/hormone-replacement-therapy2026-04-22weekly0.6 https://druglandscape.com/class/toll-like-receptor-7-tlr7-agonist2026-04-22weekly0.6 https://druglandscape.com/class/proteasome-inhibitor-immunomodulatory-agent-corticosteroid-combination2026-04-22weekly0.6 https://druglandscape.com/class/long-acting-insulin2026-04-23weekly0.6 https://druglandscape.com/class/cetp-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/kappa-opioid-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/antiseptic-disinfectant2026-04-23weekly0.6 https://druglandscape.com/class/nmda-receptor-antagonist-dissociative-anesthetic2026-04-22weekly0.6 https://druglandscape.com/class/topical-anti-inflammatory2026-04-23weekly0.6 https://druglandscape.com/class/prothrombin-complex-concentrate-pcc2026-04-22weekly0.6 https://druglandscape.com/class/dietary-supplement2026-04-23weekly0.6 https://druglandscape.com/class/cytokine-immunotherapy2026-04-23weekly0.6 https://druglandscape.com/class/antiseptic-disinfectant2026-04-22weekly0.6 https://druglandscape.com/class/cd38-directed-cytolytic-antibody-epc2026-04-20weekly0.6 https://druglandscape.com/class/antibiotic-class-varies-by-specific-agent2026-04-23weekly0.6 https://druglandscape.com/class/antibiotic-broad-class2026-04-22weekly0.6 https://druglandscape.com/class/il-1-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/chemotherapy-combination-anthracycline-alkylating-agent2026-04-22weekly0.6 https://druglandscape.com/class/kinase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/proton-pump-inhibitor-antibiotic-combination2026-04-23weekly0.6 https://druglandscape.com/class/oral-contraceptive2026-04-22weekly0.6 https://druglandscape.com/class/laba-lama-combination-bronchodilator2026-04-23weekly0.6 https://druglandscape.com/class/inactivated-bacterial-vaccine2026-04-22weekly0.6 https://druglandscape.com/class/antibacterial2026-04-23weekly0.6 https://druglandscape.com/class/provitamin-d2-compound-epc2026-04-20weekly0.6 https://druglandscape.com/class/pulmonary-surfactant-replacement2026-04-22weekly0.6 https://druglandscape.com/class/pulmonary-surfactant-replacement-therapy2026-04-23weekly0.6 https://druglandscape.com/class/chemotherapy-monoclonal-antibody-combination2026-04-23weekly0.6 https://druglandscape.com/class/antiseptic2026-04-23weekly0.6 https://druglandscape.com/class/purine-analog-immunosuppressant2026-04-22weekly0.6 https://druglandscape.com/class/anti-inflammatory-agent2026-04-23weekly0.6 https://druglandscape.com/class/il-12-23-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/topical-emollient2026-04-22weekly0.6 https://druglandscape.com/class/pyrethroid-epc2026-04-20weekly0.6 https://druglandscape.com/class/nsaid-opioid-analgesic-combination2026-04-22weekly0.6 https://druglandscape.com/class/if-channel-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/alkylating-agent-corticosteroid-combination2026-04-22weekly0.6 https://druglandscape.com/class/pyruvate-dehydrogenase-kinase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/adenosine-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/anti-vegf-agent2026-04-23weekly0.6 https://druglandscape.com/class/hydrolytic-lysosomal-glucocerebroside-specific-enzyme-epc2026-04-20weekly0.6 https://druglandscape.com/class/integrin-receptor-antagonist-epc2026-04-20weekly0.6 https://druglandscape.com/class/quinolone-antimicrobial-epc2026-04-20weekly0.6 https://druglandscape.com/class/hydrolytic-lysosomal-glycogen-specific-enzyme-epc2026-04-20weekly0.6 https://druglandscape.com/class/anthracycline-topoisomerase-inhibitor2026-04-20weekly0.6 https://druglandscape.com/class/rank-ligand-inhibitor-epc2026-04-21weekly0.6 https://druglandscape.com/class/anthracycline-antibiotic2026-04-23weekly0.6 https://druglandscape.com/class/5-aminosalicylic-acid-5-asa-derivative2026-04-23weekly0.6 https://druglandscape.com/class/cd19-targeting-monoclonal-antibody2026-04-23weekly0.6 https://druglandscape.com/class/crystalloid-intravenous-fluid-electrolyte-replacement-solution2026-04-22weekly0.6 https://druglandscape.com/class/angiotensin-ii-receptor-blocker-thiazide-like-diuretic-combination2026-04-22weekly0.6 https://druglandscape.com/class/interferon-alfa2026-04-23weekly0.6 https://druglandscape.com/class/traditional-chinese-medicine-injection2026-04-22weekly0.6 https://druglandscape.com/class/cephalosporin-antibacterial-epc2026-04-20weekly0.6 https://druglandscape.com/class/osmotic-laxative-bowel-preparation2026-04-23weekly0.6 https://druglandscape.com/class/rock-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/tricyclic-antidepressants2026-04-20weekly0.6 https://druglandscape.com/class/tricyclic-antidepressant2026-04-23weekly0.6 https://druglandscape.com/class/osmotic-laxative-bowel-preparation-agent2026-04-23weekly0.6 https://druglandscape.com/class/antiretroviral-combination-therapy-integrase-inhibitor-nucleoside-nucleotide-reverse-transcriptase-inhibitors2026-04-22weekly0.6 https://druglandscape.com/class/macrocyclic-antibiotic2026-04-23weekly0.6 https://druglandscape.com/class/triptan2026-04-23weekly0.6 https://druglandscape.com/class/macrocyclic-lactone-antiparasitic2026-04-23weekly0.6 https://druglandscape.com/class/antiretroviral-combination-therapy-nrti-protease-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/ccr3-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/ccr2-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/radioligand2026-04-23weekly0.6 https://druglandscape.com/class/radioligand-therapeutic-agent-epc2026-04-20weekly0.6 https://druglandscape.com/class/typical-antipsychotic-epc2026-04-20weekly0.6 https://druglandscape.com/class/typical-antipsychotic2026-04-23weekly0.6 https://druglandscape.com/class/antiretroviral-combination-therapy-nrti-pi2026-04-22weekly0.6 https://druglandscape.com/class/antiretroviral-combination-therapy-nrti-insti2026-04-22weekly0.6 https://druglandscape.com/class/immune-modulator2026-04-23weekly0.6 https://druglandscape.com/class/anesthetic-combination2026-04-22weekly0.6 https://druglandscape.com/class/androgen-deprivation-therapy-adt2026-04-23weekly0.6 https://druglandscape.com/class/antiretroviral-combination-therapy-nnrti-nrtis2026-04-23weekly0.6 https://druglandscape.com/class/inactivated-split-influenza-vaccine2026-04-23weekly0.6 https://druglandscape.com/class/antiretroviral-combination-therapy-nnrti-nrti-ntrti2026-04-22weekly0.6 https://druglandscape.com/class/urinary-antiseptic-combination2026-04-23weekly0.6 https://druglandscape.com/class/interferon-alpha-with-nucleoside-analog2026-04-23weekly0.6 https://druglandscape.com/class/androgen-epc2026-04-20weekly0.6 https://druglandscape.com/class/recombinant-human-growth-hormone-epc2026-04-20weekly0.6 https://druglandscape.com/class/fluoroquinolone2026-04-23weekly0.6 https://druglandscape.com/class/c1-esterase-inhibitor-c1-inh-replacement-therapy2026-04-22weekly0.6 https://druglandscape.com/class/mast-cell-stabilizer2026-04-20weekly0.6 https://druglandscape.com/class/antiretroviral-combination-protease-inhibitor-nnrti2026-04-22weekly0.6 https://druglandscape.com/class/bulk-forming-laxative-dietary-fiber-supplement2026-04-22weekly0.6 https://druglandscape.com/class/aldose-reductase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/analgesic-and-antipyretic-non-nsaid2026-04-23weekly0.6 https://druglandscape.com/class/antiretroviral-combination-integrase-inhibitor-nucleoside-reverse-transcriptase-inhibitors2026-04-22weekly0.6 https://druglandscape.com/class/meglitinide-rapid-acting-insulin-secretagogue2026-04-22weekly0.6 https://druglandscape.com/class/lipid-lowering-agent2026-04-23weekly0.6 https://druglandscape.com/class/recombinant-hepatitis-b-vaccine-with-adjuvant2026-04-23weekly0.6 https://druglandscape.com/class/menin-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/dopamine-d2-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/interferon-beta-epc2026-04-20weekly0.6 https://druglandscape.com/class/blood-product2026-04-23weekly0.6 https://druglandscape.com/class/antiretroviral-combination-nnrti-nrtis2026-04-23weekly0.6 https://druglandscape.com/class/amphenicol-class-antibacterial2026-04-20weekly0.6 https://druglandscape.com/class/vasopressin-v2-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/5-alpha-reductase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/5-ht1a-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/recombinant-protein-vaccine-with-adjuvant2026-04-23weekly0.6 https://druglandscape.com/class/recombinant-quadrivalent-hpv-vaccine2026-04-23weekly0.6 https://druglandscape.com/class/mesenchymal-stem-cell-therapy2026-04-23weekly0.6 https://druglandscape.com/class/recombinant-subunit-vaccine-with-adjuvant2026-04-23weekly0.6 https://druglandscape.com/class/neurotoxin-botulinum-toxin2026-04-22weekly0.6 https://druglandscape.com/class/vinca-alkaloid2026-04-20weekly0.6 https://druglandscape.com/class/vinca-alkaloid2026-04-23weekly0.6 https://druglandscape.com/class/aminosalicylate-epc2026-04-20weekly0.6 https://druglandscape.com/class/recombinant-virus-like-particle-vaccine2026-04-23weekly0.6 https://druglandscape.com/class/mood-stabilizer2026-04-23weekly0.6 https://druglandscape.com/class/interferon-beta-1a2026-04-23weekly0.6 https://druglandscape.com/class/diuretic2026-04-23weekly0.6 https://druglandscape.com/class/growth-factor2026-04-23weekly0.6 https://druglandscape.com/class/adenosine-receptor-agonist-epc2026-04-20weekly0.6 https://druglandscape.com/class/enzyme-asparagine-depleting-agent2026-04-23weekly0.6 https://druglandscape.com/class/remineralizing-agent2026-04-22weekly0.6 https://druglandscape.com/class/cell-therapy-regenerative-medicine-product2026-04-22weekly0.6 https://druglandscape.com/class/renin-angiotensin-system-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/vitamin-d-analogue-plus-corticosteroid-combination2026-04-22weekly0.6 https://druglandscape.com/class/vitamin-d-receptor-agonist2026-04-22weekly0.6 https://druglandscape.com/class/pet-imaging-agent-radiopharmaceutical2026-04-23weekly0.6 https://druglandscape.com/class/vitamin-d-supplement-secosteroid2026-04-22weekly0.6 https://druglandscape.com/class/antiretroviral-agents-multiple-classes-nrtis-nnrtis-pis-instis-entry-inhibitors2026-04-22weekly0.6 https://druglandscape.com/class/indirectly-acting-sympathomimetic-amines2026-04-20weekly0.6 https://druglandscape.com/class/antiplatelet-therapy-regimen2026-04-23weekly0.6 https://druglandscape.com/class/interleukin-13-antagonist-epc2026-04-20weekly0.6 https://druglandscape.com/class/microbiota-therapeutic2026-04-23weekly0.6 https://druglandscape.com/class/amide-local-anesthetic2026-04-20weekly0.6 https://druglandscape.com/class/vitamin-k-antagonist-vka2026-04-23weekly0.6 https://druglandscape.com/class/retinoid-differentiation-agent2026-04-22weekly0.6 https://druglandscape.com/class/antiplatelet-agents2026-04-22weekly0.6 https://druglandscape.com/class/vitamin-k-antagonist-oral-anticoagulant2026-04-22weekly0.6 https://druglandscape.com/class/nitroimidazole-antibiotic2026-04-23weekly0.6 https://druglandscape.com/class/pi3k-delta-and-gamma-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/rifamycin-antibacterial-epc2026-04-20weekly0.6 https://druglandscape.com/class/micronutrient-supplement2026-04-23weekly0.6 https://druglandscape.com/class/vitamin-nutritional-supplement2026-04-23weekly0.6 https://druglandscape.com/class/alpha-adrenergic-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/vitamin-nutritional-supplement2026-04-22weekly0.6 https://druglandscape.com/class/vitamin-steroid-hormone2026-04-22weekly0.6 https://druglandscape.com/class/antiplatelet-agent-anticoagulant-combination2026-04-22weekly0.6 https://druglandscape.com/class/bile-acid-epc2026-04-20weekly0.6 https://druglandscape.com/class/antiplatelet2026-04-23weekly0.6 https://druglandscape.com/class/volatile-general-anesthetic2026-04-22weekly0.6 https://druglandscape.com/class/volatile-halogenated-ether-anesthetic2026-04-22weekly0.6 https://druglandscape.com/class/volatile-inhalational-anesthetic2026-04-23weekly0.6 https://druglandscape.com/class/wnt-catenin-pathway-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/nicotinic-receptor-agonist2026-04-22weekly0.6 https://druglandscape.com/class/xanthine-oxidase-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/xanthine-oxidase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/adenosine-a2a-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/catecholamine-vasopressor2026-04-23weekly0.6 https://druglandscape.com/class/serd2026-04-23weekly0.6 https://druglandscape.com/class/live-attenuated-chimeric-vaccine2026-04-23weekly0.6 https://druglandscape.com/class/colloid-plasma-volume-expander2026-04-23weekly0.6 https://druglandscape.com/class/antiparasitic-combination2026-04-23weekly0.6 https://druglandscape.com/class/ppar-agonist2026-04-23weekly0.6 https://druglandscape.com/class/dendritic-cell-vaccine2026-04-23weekly0.6 https://druglandscape.com/class/gaba-a-receptor-modulator2026-04-23weekly0.6 https://druglandscape.com/class/alpha-1-adrenergic-agonist-nasal-decongestant2026-04-22weekly0.6 https://druglandscape.com/class/gene-therapy-aav-based2026-04-22weekly0.6 https://druglandscape.com/class/nitrofuran-antibacterial-epc2026-04-20weekly0.6 https://druglandscape.com/class/alkalizing-agent2026-04-23weekly0.6 https://druglandscape.com/class/hydrolytic-lysosomal-neutral-glycosphingolipid-specific-enzyme-epc2026-04-20weekly0.6 https://druglandscape.com/class/biguanide-dpp-4-inhibitor-combination2026-04-23weekly0.6 https://druglandscape.com/class/ssri-atypical-antipsychotic-combination2026-04-22weekly0.6 https://druglandscape.com/class/glinide-epc2026-04-20weekly0.6 https://druglandscape.com/class/acetylcholinesterase-inhibitor-with-anticholinergic-agent2026-04-22weekly0.6 https://druglandscape.com/class/folate-analog2026-04-20weekly0.6 https://druglandscape.com/class/enzyme-replacement-therapy-ert2026-04-23weekly0.6 https://druglandscape.com/class/parenteral-nutrition-formulation2026-04-23weekly0.6 https://druglandscape.com/class/parenteral-nutrition-supplement2026-04-22weekly0.6 https://druglandscape.com/class/fluoroquinolone-antibiotic-corticosteroid-combination2026-04-23weekly0.6 https://druglandscape.com/class/cardioplegic-solution2026-04-22weekly0.6 https://druglandscape.com/class/second-generation-antihistamine2026-04-20weekly0.6 https://druglandscape.com/class/cardiac-glycoside2026-04-23weekly0.6 https://druglandscape.com/class/glycolipid-disialoganglioside-directed-antibody-epc2026-04-20weekly0.6 https://druglandscape.com/class/antioxidant-vitamin-combination2026-04-22weekly0.6 https://druglandscape.com/class/mineral-supplement2026-04-23weekly0.6 https://druglandscape.com/class/fluoropyrimidine-platinum-based-chemotherapy-combination2026-04-23weekly0.6 https://druglandscape.com/class/5-ht3-receptor-antagonist-corticosteroid-combination2026-04-23weekly0.6 https://druglandscape.com/class/gnrh-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/fixed-dose-combination-analgesic-nsaid2026-04-23weekly0.6 https://druglandscape.com/class/nitrosourea-alkylating-agent2026-04-23weekly0.6 https://druglandscape.com/class/pegylated-interferon-alpha2026-04-23weekly0.6 https://druglandscape.com/class/alpha-adrenergic-agonist2026-04-20weekly0.6 https://druglandscape.com/class/corticosteroid-implant2026-04-22weekly0.6 https://druglandscape.com/class/gonadotropin-combination2026-04-23weekly0.6 https://druglandscape.com/class/penicillin-antibiotic2026-04-23weekly0.6 https://druglandscape.com/class/beta-lactam-antibiotic-nitroimidazole-antibiotic-combination2026-04-22weekly0.6 https://druglandscape.com/class/first-generation-h1-antihistamine2026-04-22weekly0.6 https://druglandscape.com/class/immunomodulator-disease-modifying-therapy-dmt2026-04-23weekly0.6 https://druglandscape.com/class/selective-h1-receptor-antagonist-antihistamine2026-04-23weekly0.6 https://druglandscape.com/class/fibrinolytic-agent-tissue-plasminogen-activator-tpa2026-04-22weekly0.6 https://druglandscape.com/class/selective-h1-receptor-antagonist-second-generation-antihistamine2026-04-23weekly0.6 https://druglandscape.com/class/fibrin-sealant-hemostatic-agent2026-04-23weekly0.6 https://druglandscape.com/class/non-standardized-fungal-allergenic-extract-epc2026-04-20weekly0.6 https://druglandscape.com/class/atp-synthase-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/corticosteroid-and-immunosuppressant2026-04-23weekly0.6 https://druglandscape.com/class/immunomodulator-synthetic-polypeptide2026-04-23weekly0.6 https://druglandscape.com/class/antimicrobial-mouthwash2026-04-22weekly0.6 https://druglandscape.com/class/peripheral-mu-opioid-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/corticosteroid-local-anesthetic-combination2026-04-23weekly0.6 https://druglandscape.com/class/selective-estrogen-receptor-degrader-serd2026-04-23weekly0.6 https://druglandscape.com/class/guanylate-cyclase-c-agonist2026-04-22weekly0.6 https://druglandscape.com/class/h-pylori-eradication-therapy-triple-therapy2026-04-22weekly0.6 https://druglandscape.com/class/fcrn-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/h1-receptor-antagonist-first-generation-antihistamine2026-04-22weekly0.6 https://druglandscape.com/class/h1-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/peroxisome-proliferator-receptor-alpha-agonist-epc2026-04-20weekly0.6 https://druglandscape.com/class/moderate-risk-qt-prolonging-agents2026-04-20weekly0.6 https://druglandscape.com/class/non-dihydropyridine-calcium-channel-blocker2026-04-23weekly0.6 https://druglandscape.com/class/selective-norepinephrine-reuptake-inhibitor-nri2026-04-23weekly0.6 https://druglandscape.com/class/h1-receptor-antagonist-mast-cell-stabilizer2026-04-23weekly0.6 https://druglandscape.com/class/h2-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/class-ic-antiarrhythmic-agent2026-04-23weekly0.6 https://druglandscape.com/class/selective-progesterone-receptor-modulator-sprm2026-04-23weekly0.6 https://druglandscape.com/class/hcv-ns3-protease-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/contraceptive2026-04-23weekly0.6 https://druglandscape.com/class/adenosine-a2a-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/carbonic-anhydrase-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/her2-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/factor-xa-inhibitor2026-04-20weekly0.6 https://druglandscape.com/class/histone-deacetylase-inhibitor-anticonvulsant-mood-stabilizer2026-04-23weekly0.6 https://druglandscape.com/class/factor-xia-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/phosphodiesterase-4-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/flt3-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/her2-targeting-antibody-drug-conjugate2026-04-23weekly0.6 https://druglandscape.com/class/phosphodiesterase-5-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/fgfr1-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/her2-neu-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/allergen-immunotherapy-vaccine2026-04-23weekly0.6 https://druglandscape.com/class/serine-protease-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/direct-acting-antiviral-combination-ns5a-inhibitor-nucleotide-polymerase-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/exosome-therapy2026-04-23weekly0.6 https://druglandscape.com/class/phosphodiesterase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/serotonin-reuptake-inhibitor2026-04-20weekly0.6 https://druglandscape.com/class/phosphodiesterase-type-5-pde5-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/hiv-1-integrase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/hmg-coa-reductase-inhibitor2026-04-20weekly0.6 https://druglandscape.com/class/hmg-coa-reductase-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/phosphodiesterase-3-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/estrogen-replacement-therapy-topical2026-04-22weekly0.6 https://druglandscape.com/class/hedgehog-pathway-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/intravenous-anesthetic-combination2026-04-22weekly0.6 https://druglandscape.com/class/5-ht2c-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/non-opioid-analgesic-monoamine-reuptake-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/non-selective-beta-adrenergic-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/non-selective-beta-blocker2026-04-23weekly0.6 https://druglandscape.com/class/intravenous-anesthetic-combination-hypnotic-opioid2026-04-23weekly0.6 https://druglandscape.com/class/estrogen-agonist-antagonist2026-04-20weekly0.6 https://druglandscape.com/class/basal-insulin-glp-1-receptor-agonist-combination2026-04-22weekly0.6 https://druglandscape.com/class/anthracycline2026-04-23weekly0.6 https://druglandscape.com/class/phytocannabinoid-preparation2026-04-22weekly0.6 https://druglandscape.com/class/anthracycline-antibiotic2026-04-23weekly0.6 https://druglandscape.com/class/insulin-analog2026-04-23weekly0.6 https://druglandscape.com/class/cholesterol-absorption-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/herbal-adaptogen2026-04-22weekly0.6 https://druglandscape.com/class/antimetabolite-chemotherapy2026-04-23weekly0.6 https://druglandscape.com/class/botulinum-toxin2026-04-23weekly0.6 https://druglandscape.com/class/live-biotherapeutic-product-probiotic2026-04-23weekly0.6 https://druglandscape.com/class/intravenous-fluid-carbohydrate-solution2026-04-22weekly0.6 https://druglandscape.com/class/herbal-combination-product2026-04-23weekly0.6 https://druglandscape.com/class/small-interfering-rna2026-04-20weekly0.6 https://druglandscape.com/class/intravenous-fluid-crystalloid-solution2026-04-22weekly0.6 https://druglandscape.com/class/herbal-extract-immunomodulator2026-04-23weekly0.6 https://druglandscape.com/class/anti-pd-1-monoclonal-antibody2026-04-23weekly0.6 https://druglandscape.com/class/herbal-extract-nootropic2026-04-22weekly0.6 https://druglandscape.com/class/antimetabolite-corticosteroid-combination2026-04-23weekly0.6 https://druglandscape.com/class/herbal-extract-phytoestrogen2026-04-22weekly0.6 https://druglandscape.com/class/plasma-volume-expander-colloid2026-04-23weekly0.6 https://druglandscape.com/class/chemotherapy-regimen-multi-agent2026-04-23weekly0.6 https://druglandscape.com/class/platinum-based-drug-epc2026-04-20weekly0.6 https://druglandscape.com/class/cancer-immunotherapy-vaccine2026-04-23weekly0.6 https://druglandscape.com/class/calcium-channel-blocker2026-04-23weekly0.6 https://druglandscape.com/class/vaccine-combination2026-04-22weekly0.6 https://druglandscape.com/class/herbal-botanical-preparation2026-04-22weekly0.6 https://druglandscape.com/class/hexavalent-vaccine2026-04-23weekly0.6 https://druglandscape.com/class/pegylated-interferon-alfa2026-04-23weekly0.6 https://druglandscape.com/class/penem-antibacterial2026-04-20weekly0.6 https://druglandscape.com/class/penicillin-class-antibacterial-with-beta-lactamase-inhibitor2026-04-20weekly0.6 https://druglandscape.com/class/pentavalent-conjugate-vaccine2026-04-23weekly0.6 https://druglandscape.com/class/trihexyphenidyl2026-04-20weekly0.6 https://druglandscape.com/class/peptide-receptor-radionuclide-therapy-prrt2026-04-22weekly0.6 https://druglandscape.com/class/beta-lactam-antibiotic-ureidopenicillin2026-04-22weekly0.6 https://druglandscape.com/class/beta-lactam-antibiotic-semi-synthetic-penicillin2026-04-23weekly0.6 https://druglandscape.com/class/beta-lactam-antibiotic-penicillin2026-04-22weekly0.6 https://druglandscape.com/class/beta-adrenergic-antagonist-non-selective-beta-blocker2026-04-22weekly0.6 https://druglandscape.com/class/phosphodiesterase-3-inhibitor2026-04-20weekly0.6 https://druglandscape.com/class/phosphodiesterase-3-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/phosphodiesterase-3-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/beta-2-adrenergic-receptor-agonist-short-acting-bronchodilator2026-04-23weekly0.6 https://druglandscape.com/class/phosphodiesterase-9-pde9-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/beta-2-adrenergic-agonist-long-acting2026-04-22weekly0.6 https://druglandscape.com/class/phosphodiesterase-4-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/photochemotherapy-agent2026-04-22weekly0.6 https://druglandscape.com/class/beta-1-adrenergic-agonist2026-04-22weekly0.6 https://druglandscape.com/class/benzodiazepine-opioid-combination2026-04-22weekly0.6 https://druglandscape.com/class/placebo2026-04-22weekly0.6 https://druglandscape.com/class/kappa-opioid-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/plasma-volume-expander-epc2026-04-20weekly0.6 https://druglandscape.com/class/plasma-kallikrein-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/plasma-volume-expander-blood-product-derivative2026-04-22weekly0.6 https://druglandscape.com/class/platelet-aggregation-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/bacterial-protein-synthesis-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/platinum-based-chemotherapeutic-agent-and-thymidylate-synthase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/platinum-based-chemotherapy-combination2026-04-23weekly0.6 https://druglandscape.com/class/platinum-based-chemotherapy-combination-antimetabolite2026-04-23weekly0.6 https://druglandscape.com/class/pleuromutilin-antibacterial2026-04-20weekly0.6 https://druglandscape.com/class/braf-inhibitor-mek-inhibitor-combination2026-04-23weekly0.6 https://druglandscape.com/class/braf-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/kappa-opioid-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/polyclonal-antithymocyte-globulin2026-04-23weekly0.6 https://druglandscape.com/class/bcl-2-bcl-xl-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/polyene-macrolide-antifungal2026-04-22weekly0.6 https://druglandscape.com/class/autologous-dendritic-cell-vaccine2026-04-23weekly0.6 https://druglandscape.com/class/polymyxin-class-antibacterial2026-04-20weekly0.6 https://druglandscape.com/class/autologous-cell-tissue-therapy2026-04-23weekly0.6 https://druglandscape.com/class/arb-statin-combination2026-04-22weekly0.6 https://druglandscape.com/class/atypical-antipsychotic-with-opioid-antagonist2026-04-22weekly0.6 https://druglandscape.com/class/potassium-channel-opener-topical-hair-growth-stimulant2026-04-22weekly0.6 https://druglandscape.com/class/potassium-channel-opener-anticonvulsant2026-04-23weekly0.6 https://druglandscape.com/class/potassium-competitive-acid-blocker-pcab-beta-lactam-antibiotic-combination2026-04-22weekly0.6 https://druglandscape.com/class/potassium-competitive-acid-blocker-beta-lactam-antibiotic-combination2026-04-22weekly0.6 https://druglandscape.com/class/potassium-sparing-diuretic2026-04-23weekly0.6 https://druglandscape.com/class/potassium-sparing-diuretic-aldosterone-antagonist2026-04-22weekly0.6 https://druglandscape.com/class/atypical-antipsychotic-ssri-combination2026-04-22weekly0.6 https://druglandscape.com/class/prodrug2026-04-23weekly0.6 https://druglandscape.com/class/progesterone2026-04-23weekly0.6 https://druglandscape.com/class/local-anesthetic-amide-type2026-04-20weekly0.6 https://druglandscape.com/class/progesterone-supplement2026-04-22weekly0.6 https://druglandscape.com/class/aryl-hydrocarbon-receptor-ahr-agonist2026-04-22weekly0.6 https://druglandscape.com/class/mrna-therapeutic2026-04-23weekly0.6 https://druglandscape.com/class/progestin-appetite-stimulant2026-04-23weekly0.6 https://druglandscape.com/class/progestin-hormonal-contraceptive2026-04-22weekly0.6 https://druglandscape.com/class/progestin-long-acting-reversible-contraceptive2026-04-22weekly0.6 https://druglandscape.com/class/progestogen2026-04-23weekly0.6 https://druglandscape.com/class/artificial-tear-lubricating-ophthalmic-solution2026-04-22weekly0.6 https://druglandscape.com/class/artificial-tear-lubricating-ophthalmic-agent2026-04-23weekly0.6 https://druglandscape.com/class/artificial-tear-lubricating-eye-drop2026-04-23weekly0.6 https://druglandscape.com/class/prostacycline-vasodilator-epc2026-04-20weekly0.6 https://druglandscape.com/class/prostaglandin-analog2026-04-20weekly0.6 https://druglandscape.com/class/artificial-tear-lubricating-agent2026-04-23weekly0.6 https://druglandscape.com/class/arsenic-compound-differentiation-agent-and-apoptosis-inducer2026-04-23weekly0.6 https://druglandscape.com/class/aromatic-l-amino-acid-decarboxylase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/ampa-receptor-antagonist2026-04-22weekly0.6 https://druglandscape.com/class/antivenom-polyclonal-antiserum2026-04-22weekly0.6 https://druglandscape.com/class/prostaglandin-analog-beta-blocker-combination2026-04-22weekly0.6 https://druglandscape.com/class/prostaglandin-analog-and-beta-blocker-combination2026-04-23weekly0.6 https://druglandscape.com/class/prostaglandin-analog-beta-blocker-combination2026-04-22weekly0.6 https://druglandscape.com/class/mtor-inhibitor-immunosuppressant-epc2026-04-20weekly0.6 https://druglandscape.com/class/protease-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/antitubercular-agent2026-04-23weekly0.6 https://druglandscape.com/class/protease-inhibitor-boosted2026-04-22weekly0.6 https://druglandscape.com/class/alk-ros1-tyrosine-kinase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/protease-inhibitor-replacement-therapy2026-04-22weekly0.6 https://druglandscape.com/class/proteasome-inhibitor2026-04-20weekly0.6 https://druglandscape.com/class/antithrombotic-combination-therapy2026-04-22weekly0.6 https://druglandscape.com/class/proteasome-inhibitor-corticosteroid-combination2026-04-22weekly0.6 https://druglandscape.com/class/antispasmodic-agent2026-04-23weekly0.6 https://druglandscape.com/class/macrolide-antibiotic2026-04-23weekly0.6 https://druglandscape.com/class/proteolytic-enzyme-combination2026-04-22weekly0.6 https://druglandscape.com/class/proton-pump-inhibitor2026-04-20weekly0.6 https://druglandscape.com/class/proton-pump-inhibitors2026-04-20weekly0.6 https://druglandscape.com/class/antiseptic-antimicrobial-agent2026-04-23weekly0.6 https://druglandscape.com/class/proton-pump-inhibitor-vonoprazan-beta-lactam-antibiotic-amoxicillin2026-04-22weekly0.6 https://druglandscape.com/class/proton-pump-inhibitor-vonoprazan-beta-lactam-antibiotic-amoxicillin-macrolide-antibiotic-clarithromycin2026-04-22weekly0.6 https://druglandscape.com/class/proton-pump-inhibitor-beta-lactam-antibiotic-combination2026-04-22weekly0.6 https://druglandscape.com/class/proton-pump-inhibitor-antibiotic-combination-therapy2026-04-22weekly0.6 https://druglandscape.com/class/proton-pump-inhibitor-beta-lactam-antibiotic-combination2026-04-23weekly0.6 https://druglandscape.com/class/proton-pump-inhibitor-dopamine-antagonist-combination2026-04-22weekly0.6 https://druglandscape.com/class/purine-antimetabolite-epc2026-04-20weekly0.6 https://druglandscape.com/class/antirheumatic-agent-epc2026-04-20weekly0.6 https://druglandscape.com/class/pyrethroid-insecticide2026-04-23weekly0.6 https://druglandscape.com/class/pyrimidine-analog2026-04-23weekly0.6 https://druglandscape.com/class/pyruvate-dehydrogenase-kinase-pdk-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/pyruvate-kinase-activator2026-04-23weekly0.6 https://druglandscape.com/class/quinoline-antimalarial2026-04-22weekly0.6 https://druglandscape.com/class/melatonin-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/quinolone-antibiotic2026-04-23weekly0.6 https://druglandscape.com/class/monoamine-oxidase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/antiretroviral-combination-therapy-protease-inhibitor-reverse-transcriptase-inhibitors2026-04-23weekly0.6 https://druglandscape.com/class/rankl-inhibitor-monoclonal-antibody2026-04-22weekly0.6 https://druglandscape.com/class/rna-splicing-modulator2026-04-23weekly0.6 https://druglandscape.com/class/rna-based-therapy2026-04-20weekly0.6 https://druglandscape.com/class/rxr-agonist2026-04-23weekly0.6 https://druglandscape.com/class/antiretroviral-combination-therapy-nrti-ntrti-nnrti2026-04-22weekly0.6 https://druglandscape.com/class/antiretroviral-combination-therapy-nrti-nnrti2026-04-23weekly0.6 https://druglandscape.com/class/radiographic-contrast-agent2026-04-22weekly0.6 https://druglandscape.com/class/radiolabeled-peptide-peptide-receptor-radionuclide-therapy-prrt2026-04-23weekly0.6 https://druglandscape.com/class/acth-analog-corticotropin2026-04-22weekly0.6 https://druglandscape.com/class/antiretroviral-combination-therapy-nnrti-nrti2026-04-23weekly0.6 https://druglandscape.com/class/antiretroviral-combination-protease-inhibitor-nucleoside-nucleotide-reverse-transcriptase-inhibitors2026-04-22weekly0.6 https://druglandscape.com/class/recombinant-human-nerve-growth-factor-epc2026-04-20weekly0.6 https://druglandscape.com/class/antiretroviral-combination-protease-inhibitor-nucleoside-reverse-transcriptase-inhibitors2026-04-22weekly0.6 https://druglandscape.com/class/recombinant-clotting-factor-viii2026-04-23weekly0.6 https://druglandscape.com/class/antiretroviral-combination-integrase-inhibitor-nucleoside-nucleotide-reverse-transcriptase-inhibitors2026-04-22weekly0.6 https://druglandscape.com/class/recombinant-coagulation-factor-replacement2026-04-23weekly0.6 https://druglandscape.com/class/recombinant-growth-factor2026-04-23weekly0.6 https://druglandscape.com/class/antiretroviral-combination-nrti-nnrti2026-04-23weekly0.6 https://druglandscape.com/class/recombinant-hormone2026-04-23weekly0.6 https://druglandscape.com/class/antiretroviral-combination-nrti-insti2026-04-22weekly0.6 https://druglandscape.com/class/recombinant-human-growth-hormone-somatropin2026-04-22weekly0.6 https://druglandscape.com/class/recombinant-influenza-vaccine2026-04-23weekly0.6 https://druglandscape.com/class/antiretroviral-combination-nnrti-nrti-ntrti2026-04-23weekly0.6 https://druglandscape.com/class/antiretroviral-combination-insti-nrtis2026-04-22weekly0.6 https://druglandscape.com/class/antiretroviral-combination-insti-nnrti2026-04-22weekly0.6 https://druglandscape.com/class/regenerative-biologic-periodontal-regenerative-material2026-04-22weekly0.6 https://druglandscape.com/class/multi-kinase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/regenerative-medicine-autologous-cell-therapy2026-04-23weekly0.6 https://druglandscape.com/class/regional-anesthetic-technique2026-04-23weekly0.6 https://druglandscape.com/class/regional-anesthetic-technique-local-anesthetic-nerve-block2026-04-22weekly0.6 https://druglandscape.com/class/renal-dehydropeptidase-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/respiratory-syncytial-virus-anti-f-protein-monoclonal-antibody-epc2026-04-20weekly0.6 https://druglandscape.com/class/antipsychotic-benzodiazepine-combination2026-04-23weekly0.6 https://druglandscape.com/class/nitroimidazole2026-04-23weekly0.6 https://druglandscape.com/class/antiplatelet-therapy-combination2026-04-22weekly0.6 https://druglandscape.com/class/antiplatelet-agent-vasodilator2026-04-22weekly0.6 https://druglandscape.com/class/antiplatelet-agent-antioxidant-lipid-lowering-agent2026-04-22weekly0.6 https://druglandscape.com/class/trimethidinium2026-04-20weekly0.6 https://druglandscape.com/class/s1pr1-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/antiparasitic-antimicrobial-combination2026-04-23weekly0.6 https://druglandscape.com/class/sglt-2-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/sglt1-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/sglt2-inhibitor-biguanide-combination2026-04-23weekly0.6 https://druglandscape.com/class/sglt2-inhibitor-biguanide-combination2026-04-23weekly0.6 https://druglandscape.com/class/snri-serotonin-norepinephrine-reuptake-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/antiparasitic-agent-macrocyclic-lactone2026-04-23weekly0.6 https://druglandscape.com/class/ssri-selective-serotonin-reuptake-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/ssri-ndri-combination-antidepressant2026-04-22weekly0.6 https://druglandscape.com/class/ssri-mood-stabilizer-combination2026-04-22weekly0.6 https://druglandscape.com/class/ssri-snri2026-04-23weekly0.6 https://druglandscape.com/class/ssri-snri-combination2026-04-22weekly0.6 https://druglandscape.com/class/antioxidant-mitochondrial-cofactor2026-04-22weekly0.6 https://druglandscape.com/class/second-generation-h1-receptor-antagonist-non-sedating-antihistamine2026-04-22weekly0.6 https://druglandscape.com/class/second-generation-antipsychotic-atypical-antipsychotic2026-04-23weekly0.6 https://druglandscape.com/class/sedative-analgesic-combination2026-04-22weekly0.6 https://druglandscape.com/class/sedative-hypnotic-gaba-a-receptor-positive-allosteric-modulator2026-04-22weekly0.6 https://druglandscape.com/class/selectin-blocker-epc2026-04-20weekly0.6 https://druglandscape.com/class/antimycobacterial-epc2026-04-20weekly0.6 https://druglandscape.com/class/antimuscarinic-agent2026-04-23weekly0.6 https://druglandscape.com/class/antimitotic-agent2026-04-23weekly0.6 https://druglandscape.com/class/octatropine-methylbromide2026-04-20weekly0.6 https://druglandscape.com/class/selective-h1-receptor-antagonist-mast-cell-stabilizer2026-04-22weekly0.6 https://druglandscape.com/class/selective-h1-receptor-antagonist-and-mast-cell-stabilizer2026-04-23weekly0.6 https://druglandscape.com/class/ocular-lubricant2026-04-23weekly0.6 https://druglandscape.com/class/selective-aldosterone-antagonist2026-04-22weekly0.6 https://druglandscape.com/class/selective-beta-1-adrenergic-antagonist-beta-blocker2026-04-23weekly0.6 https://druglandscape.com/class/selective-enzyme-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/selective-estrogen-receptor-degrader-serd-cdk4-6-inhibitor-combination2026-04-23weekly0.6 https://druglandscape.com/class/antimicrobial-lock-solution2026-04-23weekly0.6 https://druglandscape.com/class/antimicrobial-combination-therapy2026-04-22weekly0.6 https://druglandscape.com/class/selective-progesterone-receptor-modulator2026-04-23weekly0.6 https://druglandscape.com/class/antimicrobial-catheter-lock-solution2026-04-23weekly0.6 https://druglandscape.com/class/selective-retinoid-x-receptor-rxr-agonist2026-04-22weekly0.6 https://druglandscape.com/class/antimicrobial-antiseptic2026-04-22weekly0.6 https://druglandscape.com/class/antimetabolite-ribonucleotide-reductase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/selective-sodium-channel-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/serine-protease2026-04-23weekly0.6 https://druglandscape.com/class/serine-protease-inhibitor-complement-regulator2026-04-23weekly0.6 https://druglandscape.com/class/ace-inhibitor-plus-thiazide-diuretic-combination2026-04-22weekly0.6 https://druglandscape.com/class/serotonin-and-norepinephrine-reuptake-inhibitor2026-04-20weekly0.6 https://druglandscape.com/class/serotonin-modulator-and-stimulator2026-04-23weekly0.6 https://druglandscape.com/class/serotonin-precursor-amino-acid-supplement2026-04-23weekly0.6 https://druglandscape.com/class/antimetabolite-pyrimidine-analog2026-04-22weekly0.6 https://druglandscape.com/class/serotonin-receptor-modulator2026-04-23weekly0.6 https://druglandscape.com/class/antimetabolite-fluoropyrimidine2026-04-22weekly0.6 https://druglandscape.com/class/serotonin-3-receptor-antagonist2026-04-20weekly0.6 https://druglandscape.com/class/serotonin-3-receptor-antagonist-epc2026-04-20weekly0.6 https://druglandscape.com/class/serotonin-dopamine-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/antimetabolite-5-fluorouracil-prodrug2026-04-22weekly0.6 https://druglandscape.com/class/5-ht1f-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/antimetabolite-epc2026-04-20weekly0.6 https://druglandscape.com/class/single-875-mg-dose-of-mevrometostat-alternative-tablet-formulation2026-04-20weekly0.6 https://druglandscape.com/class/skin-test-antigen-epc2026-04-20weekly0.6 https://druglandscape.com/class/antimetabolite-immunosuppressant2026-04-20weekly0.6 https://druglandscape.com/class/sodium-glucose-cotransporter-2-inhibitor2026-04-20weekly0.6 https://druglandscape.com/class/antimalarial-agent-4-aminoquinoline2026-04-22weekly0.6 https://druglandscape.com/class/antimalarial-macrolide-antibiotic-combination2026-04-23weekly0.6 https://druglandscape.com/class/soluble-guanylate-cyclase-stimulator-epc2026-04-20weekly0.6 https://druglandscape.com/class/oral-immunotherapy2026-04-23weekly0.6 https://druglandscape.com/class/somatostatin-analog2026-04-20weekly0.6 https://druglandscape.com/class/antihypertensive-combination-therapy2026-04-23weekly0.6 https://druglandscape.com/class/somatostatin-analogue2026-04-23weekly0.6 https://druglandscape.com/class/antihypertensive-combination-calcium-channel-blocker-angiotensin-ii-receptor-blocker-thiazide-diuretic2026-04-22weekly0.6 https://druglandscape.com/class/spermicide2026-04-23weekly0.6 https://druglandscape.com/class/sphingosine-1-phosphate-receptor-modulator2026-04-20weekly0.6 https://druglandscape.com/class/sphingosine-1-phosphate-receptor-modulator2026-04-23weekly0.6 https://druglandscape.com/class/antihypertensive-combination-arb-thiazide-diuretic-calcium-channel-blocker2026-04-23weekly0.6 https://druglandscape.com/class/antihistamine-intranasal-corticosteroid-combination2026-04-23weekly0.6 https://druglandscape.com/class/antihistamine-and-corticosteroid-combination2026-04-23weekly0.6 https://druglandscape.com/class/statin-ezetimibe-combination2026-04-23weekly0.6 https://druglandscape.com/class/statin-and-cholesterol-absorption-inhibitor-combination2026-04-22weekly0.6 https://druglandscape.com/class/statin-and-fibrate-combination2026-04-22weekly0.6 https://druglandscape.com/class/steroid-antibiotic2026-04-22weekly0.6 https://druglandscape.com/class/steroid-hormone-prohormone2026-04-22weekly0.6 https://druglandscape.com/class/steroid-hormone-precursor2026-04-23weekly0.6 https://druglandscape.com/class/stimulant2026-04-23weekly0.6 https://druglandscape.com/class/stimulant-laxative-epc2026-04-20weekly0.6 https://druglandscape.com/class/sublingual-immunotherapy-slit-tablet2026-04-23weekly0.6 https://druglandscape.com/class/substance-p-neurokinin-1-receptor-antagonist2026-04-20weekly0.6 https://druglandscape.com/class/substance-p-neurokinin-1-receptor-antagonist-epc2026-04-20weekly0.6 https://druglandscape.com/class/subunit-vaccine2026-04-23weekly0.6 https://druglandscape.com/class/sulfonamide-antibacterial-epc2026-04-20weekly0.6 https://druglandscape.com/class/sulfonamide-antimicrobial-epc2026-04-20weekly0.6 https://druglandscape.com/class/sulfonamide-dihydrofolate-reductase-inhibitor-combination2026-04-22weekly0.6 https://druglandscape.com/class/sulfone-epc2026-04-20weekly0.6 https://druglandscape.com/class/sulfone-antibiotic2026-04-21weekly0.6 https://druglandscape.com/class/oxazolidinone-antibiotic2026-04-23weekly0.6 https://druglandscape.com/class/sulfone-antimicrobial-and-anti-inflammatory-agent2026-04-22weekly0.6 https://druglandscape.com/class/sympathomimetic2026-04-23weekly0.6 https://druglandscape.com/class/sympathomimetic-amine-anorectic2026-04-20weekly0.6 https://druglandscape.com/class/sympathomimetic-amine-vasopressor2026-04-22weekly0.6 https://druglandscape.com/class/sympathomimetic-amine-amphetamine-prodrug2026-04-22weekly0.6 https://druglandscape.com/class/sympathomimetic-amine-appetite-suppressant2026-04-22weekly0.6 https://druglandscape.com/class/partial-opioid-agonist2026-04-23weekly0.6 https://druglandscape.com/class/pharmacological-class-not-specified2026-04-20weekly0.6 https://druglandscape.com/class/synthetic-colloid-volume-expander2026-04-23weekly0.6 https://druglandscape.com/class/platinum-based-chemotherapy2026-04-23weekly0.6 https://druglandscape.com/class/synthetic-colloid-volume-expander2026-04-23weekly0.6 https://druglandscape.com/class/antifibrinolytic-agent-epc2026-04-20weekly0.6 https://druglandscape.com/class/t-cell-costimulation-blocker2026-04-22weekly0.6 https://druglandscape.com/class/polysaccharide-vaccine2026-04-22weekly0.6 https://druglandscape.com/class/t-cell-costimulation-modulator2026-04-23weekly0.6 https://druglandscape.com/class/taar1-agonist2026-04-23weekly0.6 https://druglandscape.com/class/antiepileptic-agent-sv2a-ligand2026-04-22weekly0.6 https://druglandscape.com/class/tlr7-agonist-immune-response-modifier2026-04-23weekly0.6 https://druglandscape.com/class/antiepileptic-agent-sv2a-ligand2026-04-23weekly0.6 https://druglandscape.com/class/prostacyclin-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/tnf-receptor-antagonist-tnf-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/antidote-epc2026-04-20weekly0.6 https://druglandscape.com/class/tnf-alpha-inhibitor-monoclonal-antibody2026-04-22weekly0.6 https://druglandscape.com/class/tnf-antagonist-monoclonal-antibody2026-04-22weekly0.6 https://druglandscape.com/class/ace-inhibitor-thiazide-diuretic-combination2026-04-23weekly0.6 https://druglandscape.com/class/pyrethroid2026-04-23weekly0.6 https://druglandscape.com/class/antidiarrheal2026-04-20weekly0.6 https://druglandscape.com/class/ace-inhibitor-angiotensin-ii-receptor-blocker-combination2026-04-22weekly0.6 https://druglandscape.com/class/tau-protein-aggregation-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/anticonvulsant-mood-stabilizer2026-04-22weekly0.6 https://druglandscape.com/class/taxane-chemotherapy2026-04-23weekly0.6 https://druglandscape.com/class/anticonvulsant-gabapentinoid2026-04-22weekly0.6 https://druglandscape.com/class/testosterone-replacement-therapy-trt2026-04-22weekly0.6 https://druglandscape.com/class/tetracyclic-antidepressant2026-04-22weekly0.6 https://druglandscape.com/class/tetracycline2026-04-20weekly0.6 https://druglandscape.com/class/anticoagulant-and-antiplatelet-combination2026-04-23weekly0.6 https://druglandscape.com/class/anticoagulant-antiplatelet-combination2026-04-22weekly0.6 https://druglandscape.com/class/rapid-acting-insulin-analog2026-04-23weekly0.6 https://druglandscape.com/class/anticoagulant-unfractionated-heparin2026-04-22weekly0.6 https://druglandscape.com/class/anticholinergic-bronchodilator2026-04-22weekly0.6 https://druglandscape.com/class/antibody-drug-conjugate-adc2026-04-20weekly0.6 https://druglandscape.com/class/thiazolidinedione-biguanide-combination2026-04-22weekly0.6 https://druglandscape.com/class/antibiotic-combination-therapy-with-acid-suppression2026-04-22weekly0.6 https://druglandscape.com/class/antibiotic-combination-glycopeptide-aminoglycoside2026-04-23weekly0.6 https://druglandscape.com/class/thrombopoietin-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/antibiotic-alkylating-agent2026-04-23weekly0.6 https://druglandscape.com/class/rimazolium2026-04-20weekly0.6 https://druglandscape.com/class/antibiotic-probiotic-combination2026-04-21weekly0.6 https://druglandscape.com/class/tissue-adhesive-hemostatic-agent2026-04-23weekly0.6 https://druglandscape.com/class/toll-like-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/sclerosing-agent2026-04-23weekly0.6 https://druglandscape.com/class/topical-acne-treatment-combination2026-04-22weekly0.6 https://druglandscape.com/class/antibiotic-corticosteroid-combination2026-04-22weekly0.6 https://druglandscape.com/class/topical-analgesic-counterirritant2026-04-23weekly0.6 https://druglandscape.com/class/antibiotic-phosphonic-acid-derivative2026-04-23weekly0.6 https://druglandscape.com/class/topical-antibiotic2026-04-22weekly0.6 https://druglandscape.com/class/antibiotic-multiple-classes2026-04-22weekly0.6 https://druglandscape.com/class/topical-antifungal2026-04-23weekly0.6 https://druglandscape.com/class/topical-antifungal-agent2026-04-22weekly0.6 https://druglandscape.com/class/topical-antimicrobial-agent2026-04-22weekly0.6 https://druglandscape.com/class/topical-antimicrobial-and-remineralizing-agent2026-04-22weekly0.6 https://druglandscape.com/class/topical-antimicrobial-antiseptic2026-04-22weekly0.6 https://druglandscape.com/class/topical-antimicrobial-keratolytic-agent2026-04-22weekly0.6 https://druglandscape.com/class/topical-antioxidant2026-04-22weekly0.6 https://druglandscape.com/class/antibacterial-agent-broad-category2026-04-22weekly0.6 https://druglandscape.com/class/serotonin-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/topical-antiseptic-antimicrobial2026-04-22weekly0.6 https://druglandscape.com/class/topical-antiviral2026-04-23weekly0.6 https://druglandscape.com/class/antiarrhythmic-agent2026-04-22weekly0.6 https://druglandscape.com/class/antiarrhythmic-epc2026-04-20weekly0.6 https://druglandscape.com/class/anti-tuberculous-combination-therapy2026-04-22weekly0.6 https://druglandscape.com/class/topical-corticosteroid-class-i-super-potent2026-04-22weekly0.6 https://druglandscape.com/class/anti-tuberculosis-combination-therapy2026-04-23weekly0.6 https://druglandscape.com/class/topical-corticosteroid-with-antimicrobial-agent2026-04-22weekly0.6 https://druglandscape.com/class/anti-arrhythmic2026-04-23weekly0.6 https://druglandscape.com/class/topical-fluoride-varnish2026-04-22weekly0.6 https://druglandscape.com/class/anti-angiogenic-monoclonal-antibody-chemotherapy-combination2026-04-22weekly0.6 https://druglandscape.com/class/anti-angiogenic-agent2026-04-23weekly0.6 https://druglandscape.com/class/topical-protectant2026-04-23weekly0.6 https://druglandscape.com/class/anti-androgen2026-04-23weekly0.6 https://druglandscape.com/class/anti-ige-monoclonal-antibody2026-04-22weekly0.6 https://druglandscape.com/class/sigma-1-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/topoisomerase-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/anti-cd20-monoclonal-antibody2026-04-23weekly0.6 https://druglandscape.com/class/traditional-chinese-medicine-tcm-herbal-formulation2026-04-22weekly0.6 https://druglandscape.com/class/traditional-chinese-medicine-extract2026-04-22weekly0.6 https://druglandscape.com/class/traditional-chinese-medicine-herbal-formula2026-04-22weekly0.6 https://druglandscape.com/class/traditional-chinese-medicine-herbal-plaster2026-04-23weekly0.6 https://druglandscape.com/class/angiotensin-ii-receptor-blocker-calcium-channel-blocker-combination2026-04-22weekly0.6 https://druglandscape.com/class/angiotensin-ii-receptor-blocker-arb-thiazide-diuretic-combination2026-04-22weekly0.6 https://druglandscape.com/class/angiotensin-ii-receptor-antagonist-and-statin2026-04-23weekly0.6 https://druglandscape.com/class/triple-combination-inhaler-ics-laba-lama2026-04-22weekly0.6 https://druglandscape.com/class/small-molecule-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/triple-combination-inhaler-ics-laba-lama2026-04-22weekly0.6 https://druglandscape.com/class/angiotensin-converting-enzyme-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/triterpenoid-antifungal2026-04-20weekly0.6 https://druglandscape.com/class/tubulin-inhibiting-agent-epc2026-04-20weekly0.6 https://druglandscape.com/class/angiopoietin-like-3-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/type-i-interferon-receptor-antagonist-epc2026-04-20weekly0.6 https://druglandscape.com/class/typical-antipsychotic2026-04-20weekly0.6 https://druglandscape.com/class/angiopoietin-2-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/tyrosine-kinase-inhibitor-chemotherapy-combination2026-04-22weekly0.6 https://druglandscape.com/class/tyrosine-kinase-inhibitor-combination2026-04-23weekly0.6 https://druglandscape.com/class/unknown-pharmacological-class2026-04-20weekly0.6 https://druglandscape.com/class/uricosuric-agent2026-04-23weekly0.6 https://druglandscape.com/class/urinary-alkalinizing-agent2026-04-22weekly0.6 https://druglandscape.com/class/uterotonic-agent2026-04-22weekly0.6 https://druglandscape.com/class/vegf-inhibitor-fusion-protein-chemotherapy-combination2026-04-22weekly0.6 https://druglandscape.com/class/vegf-inhibitor-monoclonal-antibody-bevacizumab-biosimilar2026-04-23weekly0.6 https://druglandscape.com/class/5-alpha-reductase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/analgesic-antipyretic-combination2026-04-23weekly0.6 https://druglandscape.com/class/vegf-inhibitor-monoclonal-antibody-bevacizumab-biosimilar2026-04-22weekly0.6 https://druglandscape.com/class/vegf-inhibitor-soluble-decoy-receptor2026-04-22weekly0.6 https://druglandscape.com/class/analgesic-antipyretic-combination-nsaid-non-nsaid2026-04-21weekly0.6 https://druglandscape.com/class/vegf-inhibitor-monoclonal-antibody2026-04-23weekly0.6 https://druglandscape.com/class/amyloid-beta-directed-antibody-epc2026-04-25weekly0.6 https://druglandscape.com/class/amylin-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/vaccine-combination2026-04-23weekly0.6 https://druglandscape.com/class/varenicline-is-classified-as-a-selective-nicotine-receptor-partial-agonist-snrpa-that-works-both-t2026-04-20weekly0.6 https://druglandscape.com/class/amylin-analog2026-04-22weekly0.6 https://druglandscape.com/class/vasoconstrictor-epc2026-04-20weekly0.6 https://druglandscape.com/class/vasodilator2026-04-22weekly0.6 https://druglandscape.com/class/vasodilator-combination2026-04-22weekly0.6 https://druglandscape.com/class/vasopressin-analog-antidiuretic-agent2026-04-22weekly0.6 https://druglandscape.com/class/vasopressin-analogue2026-04-23weekly0.6 https://druglandscape.com/class/vasopressin-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/ammonia-lowering-agent2026-04-22weekly0.6 https://druglandscape.com/class/vasopressor-agent-antidiuretic-hormone2026-04-22weekly0.6 https://druglandscape.com/class/vasopressor-combination2026-04-23weekly0.6 https://druglandscape.com/class/amino-acid-supplement-nutritional-therapeutic2026-04-23weekly0.6 https://druglandscape.com/class/vitamin2026-04-23weekly0.6 https://druglandscape.com/class/vitamin-antioxidant2026-04-23weekly0.6 https://druglandscape.com/class/vitamin-essential-nutrient2026-04-22weekly0.6 https://druglandscape.com/class/vitamin-b-complex2026-04-22weekly0.6 https://druglandscape.com/class/vitamin-b12-epc2026-04-20weekly0.6 https://druglandscape.com/class/amino-acid-supplement-nutritional-agent2026-04-23weekly0.6 https://druglandscape.com/class/amino-acid-supplement-nitric-oxide-donor2026-04-23weekly0.6 https://druglandscape.com/class/amino-acid-supplement-metabolic-agent2026-04-22weekly0.6 https://druglandscape.com/class/vitamin-d-analog-secosteroid2026-04-23weekly0.6 https://druglandscape.com/class/amino-acid-derivative-metabolic-agent2026-04-22weekly0.6 https://druglandscape.com/class/vitamin-d2-analog-epc2026-04-20weekly0.6 https://druglandscape.com/class/vitamin-d3-analog-epc2026-04-20weekly0.6 https://druglandscape.com/class/amino-acid-derivative2026-04-23weekly0.6 https://druglandscape.com/class/vitamin-k-epc2026-04-20weekly0.6 https://druglandscape.com/class/vitamin-k-analog2026-04-22weekly0.6 https://druglandscape.com/class/vitamin-k-antagonist-anticoagulant2026-04-22weekly0.6 https://druglandscape.com/class/aluminum-complex-epc2026-04-20weekly0.6 https://druglandscape.com/class/vitamin-and-mineral-supplement2026-04-22weekly0.6 https://druglandscape.com/class/alpha-beta-adrenergic-antagonist2026-04-22weekly0.6 https://druglandscape.com/class/vitamin-supplement-essential-nutrient2026-04-22weekly0.6 https://druglandscape.com/class/vitamin-antioxidant2026-04-22weekly0.6 https://druglandscape.com/class/alpha-2-adrenergic-agonist-beta-blocker-combination2026-04-22weekly0.6 https://druglandscape.com/class/volatile-anesthetic-agent2026-04-23weekly0.6 https://druglandscape.com/class/volatile-anesthetic-with-cholinesterase-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/5-ht4-receptor-partial-agonist2026-04-23weekly0.6 https://druglandscape.com/class/gabapentinoid2026-04-23weekly0.6 https://druglandscape.com/class/glp-1-receptor-agonist-biguanide-combination2026-04-22weekly0.6 https://druglandscape.com/class/gabapentinoid-anticonvulsant-anxiolytic-analgesic2026-04-23weekly0.6 https://druglandscape.com/class/glp-1-receptor-agonist-sglt2-inhibitor-combination2026-04-22weekly0.6 https://druglandscape.com/class/gadolinium-based-contrast-agent-gbca2026-04-23weekly0.6 https://druglandscape.com/class/gamma-secretase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/ganglioside2026-04-23weekly0.6 https://druglandscape.com/class/general-anesthetic2026-04-20weekly0.6 https://druglandscape.com/class/gaba-b-receptor-agonist2026-04-22weekly0.6 https://druglandscape.com/class/g-csf-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/fumaric-acid-ester-immunomodulator2026-04-22weekly0.6 https://druglandscape.com/class/ghrelin-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/free-radical-scavenger-antioxidant2026-04-23weekly0.6 https://druglandscape.com/class/fluoroquinolone-oxazolidinone-combination-antibiotic2026-04-23weekly0.6 https://druglandscape.com/class/fluoroquinolone-antibiotic-combination2026-04-22weekly0.6 https://druglandscape.com/class/glucocorticoid-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/glucosylceramide-synthase-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/glucosylceramide-synthase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/glycine-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/fluoroquinolone-antibiotic-corticosteroid-combination2026-04-23weekly0.6 https://druglandscape.com/class/fluoroquinolone-antibacterial-epc2026-04-20weekly0.6 https://druglandscape.com/class/fluoride-toothpaste2026-04-22weekly0.6 https://druglandscape.com/class/gonadotropin-recombinant-fsh2026-04-23weekly0.6 https://druglandscape.com/class/first-generation-h1-receptor-antagonist-antihistamine2026-04-23weekly0.6 https://druglandscape.com/class/alpha-blocker2026-04-23weekly0.6 https://druglandscape.com/class/gonadotropin-combination-therapy2026-04-23weekly0.6 https://druglandscape.com/class/gonadotropin-human-chorionic-gonadotropin-hcg2026-04-22weekly0.6 https://druglandscape.com/class/gonadotropin-recombinant-hormone2026-04-23weekly0.6 https://druglandscape.com/class/fibrinolytic-enzyme2026-04-22weekly0.6 https://druglandscape.com/class/growth-hormone-receptor-antagonist2026-04-20weekly0.6 https://druglandscape.com/class/fibrate-statin-combination2026-04-22weekly0.6 https://druglandscape.com/class/growth-hormone-recombinant-human-growth-hormone2026-04-23weekly0.6 https://druglandscape.com/class/growth-hormone-recombinant2026-04-23weekly0.6 https://druglandscape.com/class/fibrate-ppar-agonist2026-04-22weekly0.6 https://druglandscape.com/class/growth-hormone-analogue2026-04-23weekly0.6 https://druglandscape.com/class/growth-hormone-replacement-therapy2026-04-22weekly0.6 https://druglandscape.com/class/growth-hormone-secretagogue2026-04-23weekly0.6 https://druglandscape.com/class/guanylate-cyclase-c-agonist-epc2026-04-20weekly0.6 https://druglandscape.com/class/h1-receptor-antagonist-antihistamine2026-04-23weekly0.6 https://druglandscape.com/class/h1-receptor-antagonist-first-generation-antihistamine2026-04-23weekly0.6 https://druglandscape.com/class/farnesyltransferase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/h1-receptor-antagonist-second-generation-non-sedating-antihistamine2026-04-23weekly0.6 https://druglandscape.com/class/h2-receptor-antagonist2026-04-22weekly0.6 https://druglandscape.com/class/hbv-capsid-assembly-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/hcv-ns3-4a-protease-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/factor-xa-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/hdac6-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/her2-targeted-antibody-drug-conjugate2026-04-23weekly0.6 https://druglandscape.com/class/fxr-agonist2026-04-23weekly0.6 https://druglandscape.com/class/her2-egfr-tyrosine-kinase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/expectorant-epc2026-04-20weekly0.6 https://druglandscape.com/class/hiv-capsid-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/hiv-protease-inhibitor-boosted2026-04-22weekly0.6 https://druglandscape.com/class/alpha-adrenergic-blocker-epc2026-04-20weekly0.6 https://druglandscape.com/class/hiv-protease-inhibitor-with-pharmacokinetic-booster2026-04-22weekly0.6 https://druglandscape.com/class/aminosalicylic-acid2026-04-20weekly0.6 https://druglandscape.com/class/androgen2026-04-23weekly0.6 https://druglandscape.com/class/hematopoietic-growth-factor2026-04-23weekly0.6 https://druglandscape.com/class/hematopoietic-growth-factor-combination2026-04-23weekly0.6 https://druglandscape.com/class/hematopoietic-stem-cell-therapy2026-04-23weekly0.6 https://druglandscape.com/class/hemoglobin-s-polymerization-inhibitor2026-05-12weekly0.6 https://druglandscape.com/class/estrogen-replacement-therapy-local-vaginal2026-04-23weekly0.6 https://druglandscape.com/class/anileridine2026-04-20weekly0.6 https://druglandscape.com/class/hepatitis-b-vaccine2026-04-23weekly0.6 https://druglandscape.com/class/hepatitis-c-virus-protease-inhibitor-and-ns5a-inhibitor-combination2026-04-23weekly0.6 https://druglandscape.com/class/hepatoprotective-agent-methyl-donor2026-04-22weekly0.6 https://druglandscape.com/class/herbal-anxiolytic-sedative2026-04-22weekly0.6 https://druglandscape.com/class/herbal-combination-phytopharmaceutical2026-04-22weekly0.6 https://druglandscape.com/class/herbal-combination-phytotherapeutic-agent2026-04-23weekly0.6 https://druglandscape.com/class/herbal-combination-phytotherapeutic-agent2026-04-23weekly0.6 https://druglandscape.com/class/herbal-extract-botanical-immunomodulator2026-04-23weekly0.6 https://druglandscape.com/class/herbal-extract-hepatoprotective-agent2026-04-22weekly0.6 https://druglandscape.com/class/herbal-extract-traditional-chinese-medicine2026-04-22weekly0.6 https://druglandscape.com/class/herbal-immune-stimulant2026-04-22weekly0.6 https://druglandscape.com/class/ester-local-anesthetic2026-04-20weekly0.6 https://druglandscape.com/class/herbal-immunosuppressant2026-04-22weekly0.6 https://druglandscape.com/class/herbal-medicine-traditional-chinese-medicine2026-04-22weekly0.6 https://druglandscape.com/class/herbal-supplement-botanical-extract2026-04-23weekly0.6 https://druglandscape.com/class/erythropoiesis-stimulating-agent-esa-biosimilar2026-04-23weekly0.6 https://druglandscape.com/class/herpes-simplex-virus-nucleoside-analog-dna-polymerase-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/erythroid-maturation-agent2026-04-23weekly0.6 https://druglandscape.com/class/erythroid-maturation-agent-epc2026-04-20weekly0.6 https://druglandscape.com/class/ergot-derivative2026-04-20weekly0.6 https://druglandscape.com/class/histamine-1-receptor-inhibitor2026-04-20weekly0.6 https://druglandscape.com/class/alkylating-agents2026-04-22weekly0.6 https://druglandscape.com/class/histone-deacetylase-inhibitor2026-04-20weekly0.6 https://druglandscape.com/class/anti-inflammatory2026-04-23weekly0.6 https://druglandscape.com/class/homeopathic-remedy2026-04-23weekly0.6 https://druglandscape.com/class/enzyme-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/human-blood-coagulation-factor-epc2026-04-20weekly0.6 https://druglandscape.com/class/enzymatic-debriding-agent2026-04-23weekly0.6 https://druglandscape.com/class/human-immunodeficiency-virus-nucleoside-analog-reverse-transcriptase-inhibitor2026-04-20weekly0.6 https://druglandscape.com/class/enzymatic-debridement-agent2026-04-22weekly0.6 https://druglandscape.com/class/hyaluronic-acid-derivative2026-04-23weekly0.6 https://druglandscape.com/class/hyaluronic-acid-derivative-viscosupplement2026-04-23weekly0.6 https://druglandscape.com/class/antibody-drug-conjugate2026-04-23weekly0.6 https://druglandscape.com/class/hyperpolarized-contrast-agent2026-04-22weekly0.6 https://druglandscape.com/class/hyperpolarized-gas-contrast-agent2026-04-22weekly0.6 https://druglandscape.com/class/endothelin-receptor-antagonist-phosphodiesterase-5-inhibitor-combination2026-04-23weekly0.6 https://druglandscape.com/class/hypoxia-inducible-factor-prolyl-hydroxylase-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/ics-laba-lama-combination2026-04-23weekly0.6 https://druglandscape.com/class/idh-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/idh1-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/il-12-il-23-inhibitor-monoclonal-antibody2026-04-23weekly0.6 https://druglandscape.com/class/il-13-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/il-15-superagonist2026-04-23weekly0.6 https://druglandscape.com/class/encorafenib-will-be-administered-on-a-300-mg-qd-schedule-and-binimetinib-will-be-administered-on-a-42026-04-20weekly0.6 https://druglandscape.com/class/il-17a-inhibitor-monoclonal-antibody2026-04-23weekly0.6 https://druglandscape.com/class/alkaloid-epc2026-04-20weekly0.6 https://druglandscape.com/class/il-2-receptor-antagonist-monoclonal-antibody2026-04-22weekly0.6 https://druglandscape.com/class/electrolyte-supplement-anticonvulsant-tocolytic-agent2026-04-22weekly0.6 https://druglandscape.com/class/il-4-receptor-alpha-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/electrolyte-solution-crystalloid-fluid2026-04-22weekly0.6 https://druglandscape.com/class/electrolyte-replacement-crystalloid-fluid2026-04-22weekly0.6 https://druglandscape.com/class/il-5-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/aromatase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/echinocandin-antifungal2026-04-20weekly0.6 https://druglandscape.com/class/echinocandin2026-04-23weekly0.6 https://druglandscape.com/class/artificial-tears2026-04-23weekly0.6 https://druglandscape.com/class/dual-antiplatelet-therapy-dapt2026-04-22weekly0.6 https://druglandscape.com/class/dual-antiplatelet-agent-combination2026-04-22weekly0.6 https://druglandscape.com/class/dual-glp-1-glucagon-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/dual-glp-1-gcg-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/immunomodulator-combination2026-04-22weekly0.6 https://druglandscape.com/class/dual-fgfr-vegfr-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/immunomodulatory-agent-corticosteroid2026-04-23weekly0.6 https://druglandscape.com/class/immunomodulatory-agent-corticosteroid-combination2026-04-23weekly0.6 https://druglandscape.com/class/immunomodulatory-agent-plus-corticosteroid2026-04-23weekly0.6 https://druglandscape.com/class/immunomodulatory-peptide2026-04-23weekly0.6 https://druglandscape.com/class/dopaminergic-agonist2026-04-20weekly0.6 https://druglandscape.com/class/dopamine-2-receptor-antagonist-epc2026-04-20weekly0.6 https://druglandscape.com/class/immunosuppressant-combination-inosine-monophosphate-dehydrogenase-inhibitor-corticosteroid2026-04-23weekly0.6 https://druglandscape.com/class/dopamine-1-receptor-agonist2026-04-22weekly0.6 https://druglandscape.com/class/dopamine-replacement-therapy2026-04-23weekly0.6 https://druglandscape.com/class/dopamine-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/bacterial-vaccine2026-04-22weekly0.6 https://druglandscape.com/class/dopamine-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/dopamine-precursor-antiparkinson-agent2026-04-22weekly0.6 https://druglandscape.com/class/steroid2026-04-23weekly0.6 https://druglandscape.com/class/inactivated-influenza-vaccine-with-adjuvant2026-04-22weekly0.6 https://druglandscape.com/class/inactivated-pentavalent-vaccine2026-04-22weekly0.6 https://druglandscape.com/class/dopamine-d2-d3-receptor-antagonist-pet-imaging-agent2026-04-22weekly0.6 https://druglandscape.com/class/inactivated-viral-vaccine-combination2026-04-23weekly0.6 https://druglandscape.com/class/influenza-a-m2-protein-inhibitor2026-04-20weekly0.6 https://druglandscape.com/class/dissociative-anesthetic-and-benzodiazepine-combination2026-04-22weekly0.6 https://druglandscape.com/class/inhalation-diagnostic-agent-epc2026-04-20weekly0.6 https://druglandscape.com/class/disease-modifying-antirheumatic-drug-dmard2026-04-23weekly0.6 https://druglandscape.com/class/direct-acting-oral-anticoagulant-doac2026-04-23weekly0.6 https://druglandscape.com/class/inhaled-corticosteroid-long-acting-beta-2-agonist-combination2026-04-22weekly0.6 https://druglandscape.com/class/direct-acting-antiviral-combination-ns5a-inhibitor-ns3-4a-protease-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/beta-lactamase-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/direct-acting-antiviral-daa-combination-ns5a-inhibitor-ns3-4a-protease-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/inosine-monophosphate-dehydrogenase-impdh-inhibitor-immunosuppressant2026-04-22weekly0.6 https://druglandscape.com/class/inotropic-agent2026-04-22weekly0.6 https://druglandscape.com/class/direct-acting-antiviral-daa2026-04-22weekly0.6 https://druglandscape.com/class/insulin-premixed-biphasic-formulation2026-04-22weekly0.6 https://druglandscape.com/class/direct-renin-inhibitor-thiazide-diuretic-combination2026-04-22weekly0.6 https://druglandscape.com/class/beta-2-adrenergic-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/insulin-analog-biphasic2026-04-22weekly0.6 https://druglandscape.com/class/insulin-combination-rapid-acting-intermediate-acting2026-04-23weekly0.6 https://druglandscape.com/class/direct-renin-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/insulin-preparation2026-04-23weekly0.6 https://druglandscape.com/class/insulin-secretagogue2026-04-23weekly0.6 https://druglandscape.com/class/insulin-therapy2026-04-22weekly0.6 https://druglandscape.com/class/insulin-like-growth-factor-1-receptor-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/beta-adrenergic-agonist2026-04-20weekly0.6 https://druglandscape.com/class/diagnostic-imaging-agent-surgical-tracer2026-04-23weekly0.6 https://druglandscape.com/class/diagnostic-antigen-immunological-test2026-04-22weekly0.6 https://druglandscape.com/class/diagnostic-dye2026-04-20weekly0.6 https://druglandscape.com/class/depigmenting-agent2026-04-23weekly0.6 https://druglandscape.com/class/denosumab2026-04-23weekly0.6 https://druglandscape.com/class/interferon-gamma-blocker-epc2026-04-20weekly0.6 https://druglandscape.com/class/interferon-alpha2026-04-22weekly0.6 https://druglandscape.com/class/aldosterone-synthase-inhibitor-sglt2-inhibitor-combination2026-04-22weekly0.6 https://druglandscape.com/class/interleukin-36-receptor-antagonist-epc2026-04-20weekly0.6 https://druglandscape.com/class/interleukin-5-antagonist-epc2026-04-20weekly0.6 https://druglandscape.com/class/delta-opioid-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/data-not-available2026-04-19weekly0.6 https://druglandscape.com/class/dpp4-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/intravenous-immunoglobulin-ivig2026-04-23weekly0.6 https://druglandscape.com/class/intravenous-anesthetic2026-04-22weekly0.6 https://druglandscape.com/class/intravenous-fluid-electrolyte-replacement2026-04-22weekly0.6 https://druglandscape.com/class/dpp-4-inhibitor-biguanide-combination2026-04-23weekly0.6 https://druglandscape.com/class/intravenous-lipid-emulsion2026-04-22weekly0.6 https://druglandscape.com/class/dpp-4-inhibitor-sulfonylurea-combination2026-04-23weekly0.6 https://druglandscape.com/class/iodinated-contrast-medium2026-04-22weekly0.6 https://druglandscape.com/class/ion-exchange-resin2026-04-22weekly0.6 https://druglandscape.com/class/iron-chelator-epc2026-04-20weekly0.6 https://druglandscape.com/class/dhodh-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/cytotoxic-chemotherapy-combination2026-04-23weekly0.6 https://druglandscape.com/class/cytotoxic-agent2026-04-23weekly0.6 https://druglandscape.com/class/iso-osmolar-contrast-medium2026-04-22weekly0.6 https://druglandscape.com/class/iso-osmolar-contrast-medium-iocm2026-04-22weekly0.6 https://druglandscape.com/class/isocitrate-dehydrogenase-1-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/cytoprotective-agent2026-04-20weekly0.6 https://druglandscape.com/class/janus-kinase-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/cytomegalovirus-nucleoside-analog-dna-polymerase-inhibitor2026-04-20weekly0.6 https://druglandscape.com/class/beta-lactam-antibiotic2026-04-23weekly0.6 https://druglandscape.com/class/keratolytic-agent2026-04-22weekly0.6 https://druglandscape.com/class/cystic-fibrosis-transmembrane-conductance-regulator-potentiator-epc2026-04-20weekly0.6 https://druglandscape.com/class/lama-laba-combination-long-acting-muscarinic-antagonist-long-acting-beta-2-agonist2026-04-23weekly0.6 https://druglandscape.com/class/lhrh-agonist2026-04-23weekly0.6 https://druglandscape.com/class/lrrk2-kinase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/cyclic-lipopeptide-antibiotic2026-04-22weekly0.6 https://druglandscape.com/class/crystalloid-solution2026-04-23weekly0.6 https://druglandscape.com/class/leukotriene-receptor-antagonist-antihistamine-combination2026-04-23weekly0.6 https://druglandscape.com/class/lincosamide-antibacterial2026-04-20weekly0.6 https://druglandscape.com/class/lipase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/aldosterone-antagonist-epc2026-04-20weekly0.6 https://druglandscape.com/class/crystalloid-fluid-replacement2026-04-22weekly0.6 https://druglandscape.com/class/lipid-based-polyene-antifungal-epc2026-04-20weekly0.6 https://druglandscape.com/class/lipid-modifying-agent-combination2026-04-23weekly0.6 https://druglandscape.com/class/lipid-modifying-agent-b-vitamin2026-04-23weekly0.6 https://druglandscape.com/class/beta3-adrenergic-agonist-epc2026-04-20weekly0.6 https://druglandscape.com/class/corticotropin-acth-analog2026-04-22weekly0.6 https://druglandscape.com/class/liposomal-anthracycline-chemotherapy2026-04-23weekly0.6 https://druglandscape.com/class/liposomal-chemotherapy-combination2026-04-23weekly0.6 https://druglandscape.com/class/live-attenuated-bacillus-calmette-guerin-vaccine-epc2026-04-20weekly0.6 https://druglandscape.com/class/biguanide2026-04-23weekly0.6 https://druglandscape.com/class/corticosteroids2026-04-20weekly0.6 https://druglandscape.com/class/corticosteroid-inhaler2026-04-23weekly0.6 https://druglandscape.com/class/live-attenuated-oral-vaccine2026-04-22weekly0.6 https://druglandscape.com/class/live-attenuated-vaccine-immunostimulant2026-04-23weekly0.6 https://druglandscape.com/class/live-attenuated-vaccine-or-inactivated-vaccine2026-04-23weekly0.6 https://druglandscape.com/class/live-biotherapeutic-probiotic2026-04-22weekly0.6 https://druglandscape.com/class/live-biotherapeutic-agent2026-04-22weekly0.6 https://druglandscape.com/class/corticosteroid-alkylating-agent-combination2026-04-23weekly0.6 https://druglandscape.com/class/live-biotherapeutic-product-lbp2026-04-23weekly0.6 https://druglandscape.com/class/corticosteroid-5-ht3-receptor-antagonist-combination2026-04-22weekly0.6 https://druglandscape.com/class/corticosteroid-5-ht3-antagonist-combination2026-04-23weekly0.6 https://druglandscape.com/class/contact-laxative2026-04-22weekly0.6 https://druglandscape.com/class/local-anesthetic-regional-anesthesia-technique2026-04-22weekly0.6 https://druglandscape.com/class/local-anesthetic-corticosteroid-combination2026-04-22weekly0.6 https://druglandscape.com/class/complement-c5-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/combined-oral-contraceptive-with-anti-androgenic-activity2026-04-22weekly0.6 https://druglandscape.com/class/local-anesthetic-sodium-channel-blocker2026-04-23weekly0.6 https://druglandscape.com/class/local-anesthetic-and-opioid-analgesic-combination2026-04-23weekly0.6 https://druglandscape.com/class/local-anesthetic-combination-with-nsaid-and-vasopressor2026-04-22weekly0.6 https://druglandscape.com/class/local-anesthetic-nerve-block2026-04-22weekly0.6 https://druglandscape.com/class/local-anesthetic-nerve-block-procedure2026-04-22weekly0.6 https://druglandscape.com/class/local-anesthetic-with-adjuvant-alpha-2-agonist2026-04-22weekly0.6 https://druglandscape.com/class/combination-vaccine-inactivated-toxoid-and-acellular-pertussis2026-04-23weekly0.6 https://druglandscape.com/class/combination-therapy-biguanide-selective-estrogen-receptor-modulator-serm2026-04-22weekly0.6 https://druglandscape.com/class/combination-lipid-lowering-agent-ezetimibe-statin2026-04-22weekly0.6 https://druglandscape.com/class/long-acting-anticholinergic-long-acting-beta-2-agonist-combination-lama-laba2026-04-22weekly0.6 https://druglandscape.com/class/combination-laxative-osmotic-stimulant2026-04-22weekly0.6 https://druglandscape.com/class/combination-inhaled-corticosteroid-long-acting-beta-2-agonist-ics-laba2026-04-23weekly0.6 https://druglandscape.com/class/long-acting-beta-2-adrenergic-agonist-laba2026-04-22weekly0.6 https://druglandscape.com/class/combination-inhaled-corticosteroid-and-short-acting-beta-2-agonist-ics-saba2026-04-22weekly0.6 https://druglandscape.com/class/combination-inactivated-vaccine2026-04-22weekly0.6 https://druglandscape.com/class/long-acting-beta-2-agonist-long-acting-muscarinic-antagonist-combination-laba-lama2026-04-23weekly0.6 https://druglandscape.com/class/long-acting-beta2-adrenergic-receptor-agonist-inhaled-corticosteroid-combination2026-04-23weekly0.6 https://druglandscape.com/class/long-acting-insulin-analog2026-04-23weekly0.6 https://druglandscape.com/class/long-acting-local-anesthetic2026-04-22weekly0.6 https://druglandscape.com/class/combination-cold-and-cough-remedy2026-04-22weekly0.6 https://druglandscape.com/class/long-acting-muscarinic-antagonist-long-acting-beta-2-agonist-combination-lama-laba2026-04-22weekly0.6 https://druglandscape.com/class/combination-chemotherapy-with-immunomodulatory-agent2026-04-23weekly0.6 https://druglandscape.com/class/combination-chemotherapy-with-anti-angiogenic-monoclonal-antibody2026-04-23weekly0.6 https://druglandscape.com/class/combination-chemotherapy-with-her2-targeted-monoclonal-antibodies2026-04-23weekly0.6 https://druglandscape.com/class/loop-diuretic-and-potassium-sparing-diuretic2026-04-23weekly0.6 https://druglandscape.com/class/low-molecular-weight-heparin2026-04-20weekly0.6 https://druglandscape.com/class/broxuridine2026-04-20weekly0.6 https://druglandscape.com/class/combination-chemotherapy-and-radiation-therapy2026-04-23weekly0.6 https://druglandscape.com/class/combination-chemotherapy-and-monoclonal-antibody2026-04-23weekly0.6 https://druglandscape.com/class/mao-b-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/combination-chemotherapy-and-immunotherapy-regimen2026-04-23weekly0.6 https://druglandscape.com/class/mri-contrast-agent2026-04-23weekly0.6 https://druglandscape.com/class/combination-chemotherapy-and-immunomodulatory-therapy2026-04-22weekly0.6 https://druglandscape.com/class/macrolide-antimicrobial-epc2026-04-20weekly0.6 https://druglandscape.com/class/combination-chemotherapy-topoisomerase-i-inhibitor-antimetabolite2026-04-23weekly0.6 https://druglandscape.com/class/combination-chemotherapy-taxane-fluoropyrimidine2026-04-23weekly0.6 https://druglandscape.com/class/combination-bronchodilator-beta-2-agonist-anticholinergic2026-04-22weekly0.6 https://druglandscape.com/class/meningococcal-vaccine2026-04-23weekly0.6 https://druglandscape.com/class/metabolic-modulator2026-04-23weekly0.6 https://druglandscape.com/class/methyl-donor-hepatoprotective-agent2026-04-22weekly0.6 https://druglandscape.com/class/adsorbent-antidote2026-04-21weekly0.6 https://druglandscape.com/class/methyltransferase-inhibitor2026-04-20weekly0.6 https://druglandscape.com/class/microbiome-modulator2026-04-23weekly0.6 https://druglandscape.com/class/combination-antibiotic2026-04-23weekly0.6 https://druglandscape.com/class/cofactor-replacement-therapy2026-04-22weekly0.6 https://druglandscape.com/class/claudin-18-2-directed-cytolytic-antibody-epc2026-04-20weekly0.6 https://druglandscape.com/class/microtubule-stabilizer-taxane2026-04-22weekly0.6 https://druglandscape.com/class/microtubule-stabilizer-taxane2026-04-23weekly0.6 https://druglandscape.com/class/mineral-supplement-vitamin-supplement-combination2026-04-22weekly0.6 https://druglandscape.com/class/classical-complement-pathway-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/mitochondrial-cofactor-antioxidant2026-04-22weekly0.6 https://druglandscape.com/class/mitochondrial-complex-i-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/mitochondrially-targeted-antioxidant2026-04-23weekly0.6 https://druglandscape.com/class/clc-2-chloride-channel-activator2026-04-23weekly0.6 https://druglandscape.com/class/monoamine-oxidase-b-mao-b-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/cholesterol-absorption-inhibitor-hmg-coa-reductase-inhibitor-statin-combination2026-04-22weekly0.6 https://druglandscape.com/class/monoamine-reuptake-inhibitor-biguanide-combination2026-04-22weekly0.6 https://druglandscape.com/class/chloride-channel-activator2026-04-23weekly0.6 https://druglandscape.com/class/monoclonal-antibody-cd20-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/monoclonal-antibody-cd52-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/monoclonal-antibody-vegf-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/monoclonal-antibody-biosimilar2026-04-23weekly0.6 https://druglandscape.com/class/monoclonal-antibody-integrin-antagonist2026-04-22weekly0.6 https://druglandscape.com/class/monoclonal-antibody-glucocorticoid-combination2026-04-23weekly0.6 https://druglandscape.com/class/chemotherapy-regimen-combination-of-antimetabolite-and-topoisomerase-i-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/adrenergic-agonist2026-04-23weekly0.6 https://druglandscape.com/class/monoclonal-antibody-combination-neutralizing-antibodies2026-04-22weekly0.6 https://druglandscape.com/class/monoclonal-antibody-with-recombinant-human-hyaluronidase2026-04-23weekly0.6 https://druglandscape.com/class/chemotherapy-combination-with-monoclonal-antibody2026-04-23weekly0.6 https://druglandscape.com/class/chemotherapy-combination-with-egfr-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/mood-stabilizer-combination2026-04-22weekly0.6 https://druglandscape.com/class/cannabinoid-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/mu-opioid-receptor-agonist2026-04-22weekly0.6 https://druglandscape.com/class/chemotherapy-combination-monoclonal-antibody-anti-vegf2026-04-23weekly0.6 https://druglandscape.com/class/mucoprotective-agent2026-04-23weekly0.6 https://druglandscape.com/class/mucoprotective-agent-proton-pump-inhibitor-combination2026-04-23weekly0.6 https://druglandscape.com/class/chemotherapy-combination-monoclonal-antibody2026-04-23weekly0.6 https://druglandscape.com/class/chemotherapy-combination-taxane-nucleoside-analog2026-04-23weekly0.6 https://druglandscape.com/class/multi-target-tyrosine-kinase-inhibitor-pd-l1-inhibitor-combination2026-04-22weekly0.6 https://druglandscape.com/class/chemotherapy-combination-platinum-agent-topoisomerase-ii-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/muscle-relaxant2026-04-20weekly0.6 https://druglandscape.com/class/adoptive-cell-therapy2026-04-23weekly0.6 https://druglandscape.com/class/muscle-relaxant2026-04-22weekly0.6 https://druglandscape.com/class/muscle-relaxant-centrally-acting2026-04-23weekly0.6 https://druglandscape.com/class/muscle-relaxant-nsaid-combination2026-04-23weekly0.6 https://druglandscape.com/class/mycobacterial-cell-wall-synthesis-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/nadph-oxidase-2-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/chemotherapy-combination-antimetabolite-platinum-agent2026-04-23weekly0.6 https://druglandscape.com/class/nk1-receptor-antagonist-5-ht3-receptor-antagonist-combination2026-04-22weekly0.6 https://druglandscape.com/class/nk1-receptor-antagonist-5-ht3-receptor-antagonist-combination2026-04-22weekly0.6 https://druglandscape.com/class/chemotherapeutic-agent2026-04-23weekly0.6 https://druglandscape.com/class/chemotherapy-combination-anthracycline-taxane2026-04-23weekly0.6 https://druglandscape.com/class/adjuvanted-inactivated-influenza-vaccine2026-04-22weekly0.6 https://druglandscape.com/class/nmda-receptor-modulator2026-04-23weekly0.6 https://druglandscape.com/class/nrti2026-04-23weekly0.6 https://druglandscape.com/class/ns5b-polymerase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/chemotherapy-combination-alkylating-agent-nucleoside-analog2026-04-23weekly0.6 https://druglandscape.com/class/chemotherapy-combination-alkylating-agent-anthracycline2026-04-23weekly0.6 https://druglandscape.com/class/nsaid-analgesic-combination2026-04-22weekly0.6 https://druglandscape.com/class/nsaid-opioid-combination-analgesic2026-04-22weekly0.6 https://druglandscape.com/class/nsaid-sympathomimetic-decongestant-combination2026-04-22weekly0.6 https://druglandscape.com/class/chemokine-receptor-type-4-interaction-epc2026-04-20weekly0.6 https://druglandscape.com/class/natural-product-immunomodulator2026-04-22weekly0.6 https://druglandscape.com/class/near-infrared-fluorescent-contrast-agent2026-04-22weekly0.6 https://druglandscape.com/class/near-infrared-fluorescent-imaging-agent2026-04-23weekly0.6 https://druglandscape.com/class/neonatal-fc-receptor-blocker-epc2026-04-20weekly0.6 https://druglandscape.com/class/neuroactive-steroid-gamma-aminobutyric-acid-a-receptor-positive-modulator2026-04-20weekly0.6 https://druglandscape.com/class/neuroactive-steroid-gamma-aminobutyric-acid-a-receptor-positive-modulator-epc2026-04-20weekly0.6 https://druglandscape.com/class/neuroactive-steroid-gaba-a-receptor-positive-allosteric-modulator2026-04-23weekly0.6 https://druglandscape.com/class/cephalosporin2026-04-20weekly0.6 https://druglandscape.com/class/neuromuscular-blocker2026-04-23weekly0.6 https://druglandscape.com/class/centrally-acting-muscle-relaxant2026-04-23weekly0.6 https://druglandscape.com/class/cholesterol-absorption-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/neuropeptide2026-04-22weekly0.6 https://druglandscape.com/class/neuropeptide-agonist2026-04-22weekly0.6 https://druglandscape.com/class/central-nervous-system-stimulant-dopamine-norepinephrine-reuptake-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/ciclesonide2026-04-20weekly0.6 https://druglandscape.com/class/central-alpha-2-adrenergic-agonist2026-04-23weekly0.6 https://druglandscape.com/class/cell-based-therapy2026-04-23weekly0.6 https://druglandscape.com/class/neurotoxin-botulinum-toxin-preparation2026-04-22weekly0.6 https://druglandscape.com/class/cell-wall-synthesis-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/neutrophil-elastase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/cell-therapy-hematopoietic-stem-cell-transplant2026-04-23weekly0.6 https://druglandscape.com/class/nicotine-replacement-therapy-agent2026-04-23weekly0.6 https://druglandscape.com/class/catheter-lock-solution2026-04-22weekly0.6 https://druglandscape.com/class/nicotinic-acid-derivative-lipid-modifying-agent2026-04-22weekly0.6 https://druglandscape.com/class/catecholamine-synthesis-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/catechol-o-methyltransferase-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/nitric-oxide-releasing-topical-agent2026-04-23weekly0.6 https://druglandscape.com/class/nitrofuran-antibiotic2026-04-23weekly0.6 https://druglandscape.com/class/nitrogen-binding-agent-epc2026-04-20weekly0.6 https://druglandscape.com/class/carnitine-analog2026-04-20weekly0.6 https://druglandscape.com/class/nitroimidazole-antiparasitic2026-04-23weekly0.6 https://druglandscape.com/class/cardiac-myosin-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/cardiac-glycoside-epc2026-04-20weekly0.6 https://druglandscape.com/class/carbonic-anhydrase-inhibitor-beta-blocker-combination2026-04-22weekly0.6 https://druglandscape.com/class/carbonic-anhydrase-inhibitor-beta-adrenergic-antagonist-combination2026-04-22weekly0.6 https://druglandscape.com/class/non-depolarizing-neuromuscular-blocker2026-04-23weekly0.6 https://druglandscape.com/class/carbonic-anhydrase-inhibitor-alpha-2-adrenergic-agonist-combination2026-04-22weekly0.6 https://druglandscape.com/class/non-ionic-iodinated-contrast-agent2026-04-22weekly0.6 https://druglandscape.com/class/carbohydrate-supplement2026-04-22weekly0.6 https://druglandscape.com/class/carbapenem-antibiotic-with-beta-lactamase-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/non-opioid-analgesic-and-antipyretic2026-04-23weekly0.6 https://druglandscape.com/class/cap-dependent-endonuclease-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/non-steroidal-mineralocorticoid-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/disinfectant2026-04-23weekly0.6 https://druglandscape.com/class/cannabinoid-receptor-modulator2026-04-22weekly0.6 https://druglandscape.com/class/nondepolarizing-neuromuscular-blocking-agent2026-04-20weekly0.6 https://druglandscape.com/class/nonsteroidal-anti-inflammatory-drug-nsaid2026-04-20weekly0.6 https://druglandscape.com/class/cannabinoid-epc2026-04-20weekly0.6 https://druglandscape.com/class/calcium-sensing-receptor-agonist2026-04-20weekly0.6 https://druglandscape.com/class/nonsteroidal-anti-inflammatory-drug-nsaid-combination2026-04-22weekly0.6 https://druglandscape.com/class/calcium-sensitizer-inotropic-agent2026-04-22weekly0.6 https://druglandscape.com/class/nonsteroidal-antiandrogen2026-04-23weekly0.6 https://druglandscape.com/class/calcium-channel-blocker-thiazide-diuretic-combination2026-04-22weekly0.6 https://druglandscape.com/class/calcium-channel-blocker-ace-inhibitor-combination2026-04-22weekly0.6 https://druglandscape.com/class/nrf2-activator2026-04-23weekly0.6 https://druglandscape.com/class/nucleos-t-ide-reverse-transcriptase-inhibitor-nucleos-t-ide-polymerase-inhibitor2026-04-22weekly0.6 https://druglandscape.com/class/calcitonin-gene-related-peptide-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/calcitonin-epc2026-04-20weekly0.6 https://druglandscape.com/class/nucleoside-analog-antimetabolite-chemotherapy2026-04-23weekly0.6 https://druglandscape.com/class/calcitonin-gene-related-peptide-receptor-antagonist-epc2026-04-20weekly0.6 https://druglandscape.com/class/calcitonin-gene-related-peptide-receptor-antagonist2026-04-20weekly0.6 https://druglandscape.com/class/calcitonin-gene-related-peptide-antagonist-epc2026-04-20weekly0.6 https://druglandscape.com/class/nucleoside-analog-antimetabolite-chemotherapy2026-04-23weekly0.6 https://druglandscape.com/class/nucleoside-analogue2026-04-23weekly0.6 https://druglandscape.com/class/calcineurin-inhibitor-and-mtor-inhibitor-combination2026-04-22weekly0.6 https://druglandscape.com/class/calcineurin-inhibitor-antimetabolite-immunosuppressant-combination2026-04-22weekly0.6 https://druglandscape.com/class/5-ht4-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/nucleoside-nucleotide-reverse-transcriptase-inhibitor-nrti-ntrti2026-04-23weekly0.6 https://druglandscape.com/class/erythropoiesis-stimulating-protein2026-04-23weekly0.6 https://druglandscape.com/class/nutraceutical-dietary-supplement2026-04-23weekly0.6 https://druglandscape.com/class/cyp17a1-inhibitor-androgen-synthesis-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/cyp17a1-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/eye-lubricant2026-04-23weekly0.6 https://druglandscape.com/class/omega-3-polyunsaturated-fatty-acid2026-04-22weekly0.6 https://druglandscape.com/class/oncolytic-immunotherapy2026-04-23weekly0.6 https://druglandscape.com/class/oncolytic-virus2026-04-23weekly0.6 https://druglandscape.com/class/ophthalmic-irrigating-solution2026-04-22weekly0.6 https://druglandscape.com/class/ophthalmic-lubricant-artificial-tear2026-04-22weekly0.6 https://druglandscape.com/class/ctla-4-fusion-protein-t-cell-costimulation-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/cox-2-inhibitor-corticosteroid-combination2026-04-23weekly0.6 https://druglandscape.com/class/opioid-agonist-combination2026-04-22weekly0.6 https://druglandscape.com/class/cox-2-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/cmv-terminase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/opioid-analgesic-local-anesthetic-combination2026-04-23weekly0.6 https://druglandscape.com/class/opioid-analgesic-nsaid-combination2026-04-22weekly0.6 https://druglandscape.com/class/cftr-modulator-combination2026-04-23weekly0.6 https://druglandscape.com/class/opioid-analgesic-combined-with-local-anesthetic2026-04-22weekly0.6 https://druglandscape.com/class/fesoterodine2026-04-20weekly0.6 https://druglandscape.com/class/opioid-analgesic-abuse-deterrent-formulation2026-04-22weekly0.6 https://druglandscape.com/class/opioid-analgesic-nsaid2026-04-23weekly0.6 https://druglandscape.com/class/cd4-receptor-antagonist2026-04-23weekly0.6 https://druglandscape.com/class/cd30-targeting-antibody-drug-conjugate2026-04-23weekly0.6 https://druglandscape.com/class/optical-imaging-agent2026-04-20weekly0.6 https://druglandscape.com/class/oral-anticoagulant2026-04-22weekly0.6 https://druglandscape.com/class/cd30-directed-immunoconjugate-epc2026-04-20weekly0.6 https://druglandscape.com/class/cd3-directed-antibody-epc2026-04-20weekly0.6 https://druglandscape.com/class/orexin-receptor-antagonist-epc2026-04-20weekly0.6 https://druglandscape.com/class/cd25-directed-cytotoxin-epc2026-04-20weekly0.6 https://druglandscape.com/class/cd22-directed-immunoconjugate-epc2026-04-20weekly0.6 https://druglandscape.com/class/organophosphate-insecticide2026-04-23weekly0.6 https://druglandscape.com/class/ornithine-decarboxylase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/osmotic-laxative-epc2026-04-20weekly0.6 https://druglandscape.com/class/cd20-directed-cytolytic-antibody2026-04-20weekly0.6 https://druglandscape.com/class/osmotic-agent-hypertonic-saline2026-04-23weekly0.6 https://druglandscape.com/class/osmotic-and-stimulant-laxative-combination2026-04-22weekly0.6 https://druglandscape.com/class/cd19-directed-cytolytic-antibody-epc2026-04-20weekly0.6 https://druglandscape.com/class/osmotic-laxative-bowel-preparation-agent2026-04-23weekly0.6 https://druglandscape.com/class/osmotic-laxative-bowel-cleanser2026-04-22weekly0.6 https://druglandscape.com/class/oxazolidinone-antibacterial-epc2026-04-20weekly0.6 https://druglandscape.com/class/cd19-directed-chimeric-antigen-receptor-epc2026-04-20weekly0.6 https://druglandscape.com/class/cb2-receptor-agonist2026-04-23weekly0.6 https://druglandscape.com/class/p2y12-platelet-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/fluoride-toothpaste2026-04-23weekly0.6 https://druglandscape.com/class/topical-corticosteroid2026-04-23weekly0.6 https://druglandscape.com/class/activin-receptor-ligand-trap2026-04-23weekly0.6 https://druglandscape.com/class/bronchodilator2026-04-23weekly0.6 https://druglandscape.com/class/botanical-herbal-preparation2026-04-22weekly0.6 https://druglandscape.com/class/pcsk9-inhibitor-epc2026-04-20weekly0.6 https://druglandscape.com/class/botanical-nutraceutical-antioxidant2026-04-23weekly0.6 https://druglandscape.com/class/botanical-extract-polyphenol-antioxidant2026-04-23weekly0.6 https://druglandscape.com/class/pd-1-inhibitor-with-hyaluronidase-enzyme2026-04-23weekly0.6 https://druglandscape.com/class/bitter-taste-receptor-agonist2026-04-22weekly0.6 https://druglandscape.com/class/bisphosphonate-vitamin-d3-combination2026-04-22weekly0.6 https://druglandscape.com/class/pd-l1-inhibitor-vegf-inhibitor-combination2026-04-23weekly0.6 https://druglandscape.com/class/bispecific-monoclonal-antibody-dual-checkpoint-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/bispecific-antibody-immune-checkpoint-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/bispecific-antibody-cytokine-fusion2026-04-23weekly0.6 https://druglandscape.com/class/pet-imaging-agent-radiotracer2026-04-23weekly0.6 https://druglandscape.com/class/biomaterial-wound-healing-agent2026-04-22weekly0.6 https://druglandscape.com/class/bioflavonoid-combination2026-04-23weekly0.6 https://druglandscape.com/class/bile-acid-receptor-agonist2026-04-22weekly0.6 https://druglandscape.com/class/pi3k-akt-mtor-pathway-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/hormone2026-04-23weekly0.6 https://druglandscape.com/class/plk1-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/ppar-gamma-agonist2026-04-22weekly0.6 https://druglandscape.com/class/psma-targeted-pet-imaging-agent2026-04-23weekly0.6 https://druglandscape.com/class/pthrp-analogue2026-04-23weekly0.6 https://druglandscape.com/class/bile-acid-sequestrant2026-04-20weekly0.6 https://druglandscape.com/class/biguanide-glp-1-receptor-agonist-combination2026-04-23weekly0.6 https://druglandscape.com/class/abuse-deterrent-opioid-analgesic2026-04-22weekly0.6 https://druglandscape.com/class/beta-lactam-antibiotic-and-macrolide-antibiotic-combination2026-04-22weekly0.6 https://druglandscape.com/class/atr-kinase-inhibitor2026-04-23weekly0.6 https://druglandscape.com/class/pediculicide-epc2026-04-20weekly0.6